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ABSTRACT 
CLINICAL OUTCOMES INVOLVING  
THE USE OF EXTRACORPOREAL MAGNETIC INNERVATION  
IN THE TREATMENT OF URINARY INCONTINENCE 
by 
KATHY E. DAVIS 
Urinary incontinence affects approximately 25 million Americans, significantly 
diminishing their function and quality of life.  It is estimated that 50% of all women will 
experience some form of urinary incontinence in their lifetime.  Although women are 
disproportionately affected by urinary incontinence, 69% of men who have undergone 
prostatectomy also report post-surgical incontinence. 
Extracorporeal Magnetic Innervation (ExMI) is a novel conservative approach to 
the treatment of urinary incontinence.   As a patient sits fully clothed on a chair, an 
electromagnet delivers a timed magnetic field that penetrates the pelvic floor, inducing a 
nerve impulse that prompts contractions of the muscles of the pelvic floor.  When the 
magnet is switched off, the muscles relax.  This forced, passive exercise of the pelvic 
floor muscles serves to build endurance and strengthen the muscles supporting the 
bladder during times of physical stress such as coughing, laughing or running. 
This study is a descriptive, retrospective analysis of data collected from a 
specialty continence center within a major Atlanta metropolitan outpatient facility.  The 
records for all patients who received ExMI from 2000 to 2012 were reviewed. Of the 43 
patients who had received ExMI, 35 met study inclusion criteria.  Eight patients were 
eliminated from the study. Four of these patients experienced ExMI benefits for 
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conditions unrelated to urinary incontinence and are discussed.  Data were analyzed using 
descriptive and inferential statistics. . 
 The majority of the patients were women (n=26, 74%); most patients had stress 
urinary incontinence (n=16, 46%) or mixed urinary incontinence (n=12, 34%).  The 
patient outcome was determined by comparing the pad usage before treatment and at the 
end of treatment (16 weeks).  The average number of pads used daily was significantly 
reduced to 1.6 3 + 0.94 (p<.0001).  Treatment with ExMI for urinary incontinence was 
briefly popular in the United States shortly after it was introduced.  Although ExMI is 
used extensively across Europe and Asia, very few studies on the efficacy of ExMI 
appear in the literature.   These results will add to this body of knowledge.   
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CHAPTER I 
 
INTRODUCTION 
 
Urinary incontinence is defined as the involuntary loss of urine from the bladder 
(Craven & Hirnle, 2003). According to Sakamoto, Sharma, and Wheeler (2007) this is a 
problem that affects approximately 25 million Americans.  Anatomical differences, 
trauma that can occur during childbirth and hormonal changes brought about by 
menopause predispose women to be disproportionately affected by urinary incontinence 
more than men (Katz, 2009). It is estimated that 50% of all women will experience some 
form of urinary incontinence in their lifetime (Melville, Katon, Delaney, & Newton, 
2005; Huang et al., 2006).  The overall prevalence of urinary incontinence in ambulatory 
men is reported at around 30% (Smoger, Felice, & Kloecker, 2000). Of men who have 
undergone radical prostatectomy, up to 69% have reported some post-surgical 
incontinence (Hollenbeck et al., 2002). It is of interest that men report more social 
limitation and more frustration and shame from urinary incontinence than women 
 (Lagro-Janssen, Hilkens, Klaasen, & Teunissen, 2008). 
It is difficult to predict the financial cost of urinary incontinence with any 
precision since most projections fail to take into consideration inflation and increases in  
the cost of medical care and supplies, however, the yearly expense of incontinence care is 
estimated at over $27 billion.  This expense is attributed to catheters, containment 
devices, laundry services, medical care for infections, injuries sustained in falls, 
prolonged hospital stays, and the indirect costs of lost time from work for patients or 
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caregivers (Kerr, 2005; Landefeld, et al., 2008).  In addition to the high financial cost of 
urinary incontinence, there is personal degradation from the negative physical, social, and 
emotional impact of this dysfunction.  
Urinary incontinence is categorized according to etiology and is commonly 
referred to as stress, urge, mixed, reflex, overflow, or functional incontinence. Stress and 
mixed urinary incontinence (symptoms of both stress and urge) predominate (Diokno et 
al., 2003; Kristensen, Eldoma, Williamson, Wood, & Mainprize, 2010). Treatment is 
based on the type of incontinence the patient is experiencing and includes self-
management strategies, behavioral therapies, pelvic floor rehabilitation, medications and 
surgery.   
Problem Statement 
 Although therapies exist, many people continue to live with the physical and 
psychological distress of urinary incontinence.  Control over urination is learned in early 
childhood, so loss of this control in adulthood is a demoralizing condition that has been 
described as “a disfigurement of self” (Nahon, Dorey, Waddington, & Adams, 2009). 
The reasons for living with urinary incontinence are varied. Hagglund & Wadensten 
(2007) suggest that living with the shame of incontinence and fear of humiliation prevent 
some patients from seeking care for incontinence. Too embarrassed to discuss this 
problem with their nurse or doctor, they try to manage the incontinence on their own. 
Some patients think that being incontinent is to be expected with aging, and not viewed 
as abnormal (Newman, 1998) while others do not think that there is any effective 
treatment (MacKay & Hemmett, 2001).  According to Newman (1998) most women will 
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wait approximately three years before seeking medical care for urinary incontinence, 
whereas men will seek help within six months. 
 Urinary incontinence has a negative impact on emotional health and self-esteem 
(Fultz & Herzog, 2001; MacKay & Hemmett, 2001) and significantly diminishes 
function and quality of life (Melville, Katon, Delaney, & Newton, 2005). Patients have 
reported sleep disturbances related to eneuretic episodes.  Complaints of interrupted sleep 
resulting in next day exhaustion, or no longer sleeping with their partner so that their 
partner’s sleep is not disturbed are commonly expressed (Palmer, Fogarty, Somerfield, & 
Powel, 2003). These patients experience a higher incidence of depression and lower self-
esteem that they believe negatively affects their work performance and social activities 
(Yeung et al., 2003).  
Incontinence is frequently cited as being a barrier to physical activity.  Brown & 
Miller (2001) examined results from the Australian Longitudinal Study on Women’s 
Health Survey (ALSWH) to ascertain both the prevalence of urinary incontinence and 
whether women perceived the incontinence to be a barrier to physical activity.  The 
ALSWH has been collecting information on physical, psychological and social aspects of 
women’s health since 1996. At that time over 40,000 women were included in the 
baseline study.  Data was collected from young (18-23), middle age (45-50), and older 
women (79-75) with regard to their experience of urinary incontinence.   All age groups 
reported episodes of urinary incontinence. In 1999 a follow up survey to examine the 
relationship between incontinence and physical activity was sent to 1500 women who had 
participated in the baseline survey.  Over 1000 women participated in the follow-up 
survey. Overall, 89% of respondents reported leaking urine when coughing or laughing, 
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and more than 40% reported leaking when engaged in physical exercise. These women 
described a variety of management strategies to avoid or minimize incontinence while 
participating in any sort of physical exercise.  More than one third of middle aged women 
and one quarter of older women completely avoided physical activity due to their 
incontinence. Similar self-imposed modifications and restrictions to recreation and 
physical functions such as walking, running, lifting, and carrying have also been reported 
in the literature (Brocklehurst, 1993; Hagglund, Walker-Engstrom, Larsson, & Leppert, 
2004; St. John, Wallis, Griffiths, & McKenzie, 2010). 
 Living with incontinence on a daily basis, wearing sanitary pads or diapers, 
choosing clothing that can conceal a leak, and frequent washing to prevent odors can all 
negatively affect a person’s self-image and sexuality. Incontinence has been shown to 
cause a loss of libido and sexual dysfunction that can result in barriers to healthy 
relationships (Katz, 2009).  All the work that goes into daily management of urinary 
incontinence as well as the involuntary loss of urine during sexual intercourse have been 
cited as having a major negative impact on sexual relations (O’Connell, Baker, & Munro, 
2007).  In a study of 166 men who had undergone prostatectomy, 114 (69%) reported 
problems with urinary incontinence, management of urinary incontinence and coping. 
Patients found the social limitations of urinary incontinence to be the most difficult. 
These men voiced their reluctance to become sexually involved in the future for fear that 
their incontinence would be discovered (Palmer, Fogarty, Somerfield, & Powel, 2003).   
 Compounding the financial costs and psychological toll, there are other risks 
associated with urinary incontinence. Incontinence-associated dermatitis (IAD) of the 
perineum has been reported in up to 50% of persons who suffer with incontinence. 
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Inflammation of the skin with erythema, edema and erosion of superficial layers of skin 
is characteristic of IAD.  In reviewing the existing literature, several factors were found 
to contribute to the development of IAD including the patient’s age, general health, 
nutrition, friction/shear, volume and frequency of incontinence (Gray et al, 2007; 
Langemo, Hanson, Hunter, Thompson, & Oh, 2011). These skin injuries add to the 
physical misery as well as the economic burden.   
Falls and resultant injuries are serious concerns for persons with urinary 
incontinence. They threaten independence and are the leading cause of death in persons 
over the age of 65 (Brady & Lamb, 2008). Byles, Millar, Sibbritt, & Chiarelli (2009) 
examined ALSWH data and found a positive correlation between the incidence of falls in 
older women with incontinence.  Hasegawa, Masafumi, & Iguchi (2009) conducted a 
study with over one thousand participants, both men and women.  Their study also 
indicated that recurrent and injurious falls have been associated with urinary incontinence 
and are prevalent in long-term care facilities among the elderly who are frail and who 
have comorbid conditions including diabetes, cancer, hypertension, osteoporosis and 
dementia.   
 Clearly urinary incontinence is a major healthcare problem that negatively affects 
millions of people.  The physical discomfort and potential risk of injury related to 
incontinence is compounded by the personal and social burden that accompanies it. 
Urinary incontinence also poses a challenge to healthcare professionals and drains 
available resources. First line treatment for urinary incontinence includes the use of pads, 
behavioral modification and conservative, self-management strategies such as fluid, diet, 
and bowel management. Patients may also be taught how to perform Kegel exercises to 
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strengthen the pelvic floor.  If these techniques fail to provide the desired continence, 
more aggressive therapies, including pessaries, biofeedback, electrical stimulation, 
medications, the injection of bulking agents or surgery may be the next step. There is 
another treatment modality that uses pulsed electromagnetic fields to force pelvic muscle 
contraction. Extracorporeal magnetic innervation (ExMI), the use of pulsed 
electromagnetic fields in the treatment of urinary incontinence, is a non-invasive, 
conservative treatment that has been available for more than a decade, but there is little in 
the literature regarding the effectiveness of this treatment.  This study will add to the 
body of knowledge of the effectiveness of ExMI. 
Purpose of the Study 
 The purpose of this study is to describe clinical outcomes for patients who were 
treated with ExMI for stress, urge and mixed urinary incontinence.  Clinical outcomes are 
the end results of treatment effectiveness, length of time this effectiveness lasts, and any 
benefits unrelated to urinary incontinence. The literature has shown that electromagnetic 
pulse therapy can have other beneficial effects.  Although ExMI is intended for the 
treatment of urinary incontinence, end results unrelated to urinary incontinence will be 
included in clinical outcomes. 
Specific objectives of the study  
1. Examine the differences in selected demographics (age in years, gender, race, 
weight in pounds) and relationship among health behaviors (dietary/fluid 
management, bowel management, Kegel exercises), medications (diuretics, 
central nervous system [CNS] depressants, hormones, anticholinergics, 
antihistamines, others as appropriate to bladder function), substance use 
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(tobacco, caffeine, alcohol), physical findings (cystocele, rectocele, uterine 
prolapse, vaginal/rectal tone/grip), medical history (length of incontinence, 
pelvic surgery, cardiovascular disease, hypertension, diabetes, neurologic 
disorders, stroke, COPD/asthma, bladder/kidney infections, 
pelvic/abdominal/back pain, pregnancies, methods of delivery, number of 
wetting episodes and number of pads used per day prior to treatment), 
between patients with stress urge, and mixed urinary incontinence. 
2. Explore the relationship of selected demographics (age in years, gender, race, 
weight in pounds) and health behaviors (dietary/fluid management, bowel 
management, Kegel exercises), medications (diuretics, central nervous system  
[CNS] depressants, hormones, anticholinergics, antihistamines, others as 
appropriate to bladder function), substance use (tobacco, caffeine, alcohol), 
physical findings (cystocele, rectocele, uterine prolapse, vaginal/rectal 
tone/grip), medical history (length of incontinence, pelvic surgery, 
cardiovascular disease, hypertension, diabetes, neurologic disorders, stroke, 
COPD/asthma, bladder/kidney infections, pelvic/abdominal/back pain, 
pregnancies, methods of delivery, number of wetting episodes and number of 
pads used per day prior to treatment), and post-treatment wetting episodes 
following ExMI treatment for urinary incontinence. 
3. Explore the relationship of selected demographics (age in years, gender, race, 
weight in pounds) and health behaviors (dietary/fluid management, bowel 
management, Kegel exercises), medications (diuretics, central nervous system  
[CNS] depressants, hormones, anticholinergics, antihistamines, others as 
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appropriate to bladder function), substance use (tobacco, caffeine, alcohol), 
physical findings (cystocele, rectocele, uterine prolapse, vaginal/rectal 
tone/grip), medical history (length of incontinence, pelvic surgery, 
cardiovascular disease, hypertension, diabetes, neurologic disorders, stroke, 
COPD/asthma, bladder/kidney infections, pelvic/abdominal/back pain, 
pregnancies, methods of delivery, number of wetting episodes and number of 
pads used per day prior to treatment), and post-treatment pad usage following 
ExMI treatment for urinary incontinence. 
4. Describe the patients who experienced relapse in urinary incontinence after 
treatment with ExMI and any benefits received unrelated to reduction of 
urinary incontinence. 
5. Examine the differences in selected demographics (age in years, gender, race, 
weight in pounds) and health behaviors (dietary/fluid management, bowel 
management, Kegel exercises), medications (diuretics, central nervous system  
[CNS] depressants, hormones, anticholinergics, antihistamines, others as 
appropriate to bladder function), substance use (tobacco, caffeine, alcohol), 
physical findings (cystocele, rectocele, uterine prolapse, vaginal/rectal 
tone/grip), medical history (length of incontinence, pelvic surgery, 
cardiovascular disease, hypertension, diabetes, neurologic disorders, stroke, 
COPD/asthma, bladder/kidney infections, pelvic/abdominal/back pain, 
pregnancies, methods of delivery, number of wetting episodes and number of 
pads used per day prior to treatment), wetting episodes, and pad usage 
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between patients who do not relapse following ExMI treatment and those who 
do. 
Research objectives were modified due to sample size limitations and available 
information that was documented in the archived records.  The revised research 
objectives are as follows and will be referred to in the following chapters. 
1. Examine the differences in selected demographics (age in years, gender, 
weight in pounds) and relationship among health behaviors (dietary/fluid 
management, bowel management), medications (diuretics, central nervous 
system [CNS] depressants, hormones, anticholinergics, antihistamines, others 
as appropriate to bladder function), physical findings (cystocele, rectocele, 
uterine prolapse, vaginal/rectal tone/grip), medical history (length of 
incontinence, pelvic surgery, cardiovascular disease, hypertension, diabetes, 
neurologic disorders, stroke, COPD/asthma, bladder/kidney infections, 
pelvic/abdominal/back pain, pregnancies, methods of delivery, and number of 
pads used per day prior to treatment), between patients with stress, urge, and 
mixed urinary incontinence. 
2. Explore the relationship of selected demographics (age in years, gender, 
weight in pounds) and health behaviors (dietary/fluid management, bowel 
management), medications (diuretics, central nervous system  [CNS] 
depressants, hormones, anticholinergics, antihistamines, others as appropriate 
to bladder function),  physical findings (cystocele, rectocele, uterine prolapse, 
vaginal/rectal tone/grip), medical history (length of incontinence, pelvic 
surgery, cardiovascular disease, hypertension, diabetes, neurologic disorders, 
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stroke, COPD/asthma, bladder/kidney infections, pelvic/abdominal/back pain, 
pregnancies, methods of delivery, and number of pads used per day prior to 
treatment), and post-treatment pad usage following ExMI treatment for 
urinary incontinence. 
3. Describe the patients who returned for additional ExMI treatments. 
4.   Describe any benefits received unrelated to reduction of urinary incontinence. 
Conceptual Framework 
 The framework for this study is based on scientific concepts including the 
physiology of micturition and the physics of pulsed electromagnetic fields. 
Physiology of Micturition 
 Normal micturition is a highly synchronized act involving both involuntary and 
voluntary mechanisms.  There are storage and evacuation phases that must be 
coordinated between the bladder and urinary sphincters so that continence is maintained. 
During the storage phase, sympathetic stimulation keeps the detrusor muscle of the 
bladder relaxed, and the internal urethral sphincter contracted. As the bladder fills with 
urine and the volume reaches about 200 mL, stretch receptors in the bladder stimulate the 
spinal cord at the level of S2-S4.  This information is relayed to the pontine micturition 
center in the brain which becomes activated resulting in the urge to void. Voiding occurs 
when parasympathetic stimulation relaxes the internal urethra, and causes the detrusor 
muscle to contract. Sympathetic nervous system stimulation closes the internal urethral 
sphincter and at the same time allows for conscious control over voiding through 
voluntary contraction of the external urethral sphincter. When the time and place are 
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appropriate, conscious voluntary relaxation of the external sphincter is allowed so that the 
bladder can empty (Athwal et al., 2001; Blok, Sturms, & Holstege, 1998; Porth, 2011).  
Types of Urinary Incontinence 
 Stress Incontinence. Pelvic floor muscle support is critical to the maintenance of 
continence. The levator ani is the largest and most important muscle of the pelvic floor.  
It forms a sling that supports and holds the pelvic organs in place as well as helps to 
maintain voluntary control over urination in coordination with the parasympathetic and 
sympathetic nervous systems, bladder, and urethral sphincters (Moore & Dalley, 1999).  
Overstretched and ruptured connective tissue, muscle, and nerve fibers result in loss of 
muscle tone and result in poor support of the bladder and urinary sphincter (Baessler & 
Schuessler, 2003).  Neuromuscular and connective tissue damage from overstretching has 
been associated with vaginal delivery.  A sudden increase in intra-abdominal pressure 
such as in coughing or sneezing, or physical activity such as lifting or running can result 
in the involuntary loss of urine known as stress incontinence (Keyock & Newman, 2011). 
 Vaginal and periurethral tissues are sensitive to the effects of circulating estrogen.  
It is believed that estrogen increases urethral closure pressure which helps to maintain 
continence (Robinson & Cardozo, 2003). Low estrogen levels just prior to menstruation 
and after menopause have been linked to lowered urethral closure pressure and weakened 
sphincter muscles (Palmieri et al., 2007). When urethral pressure is lowered, the chance 
of leakage with a sudden rise in intra-abdominal pressure increases. Post menopause, as 
the urethral lining thins, the structural support for the bladder is reduced, again, 
increasing the chance for stress incontinence to occur. 
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 In patients who smoke, research suggests there may be a link between 
incontinence and the synthesis of collagen (Bottomley, 2000; Bump & McClish, 1992).  
Collagen in connective tissue is essential for providing pelvic floor support and lack of 
adequate pelvic floor support may be in part due to abnormal collagen synthesis (Wong, 
Harmanli, Agar, Dandolu, & Grody, 2003). The periurethral tissues are comprised mainly 
of type I and type III collagens. Smoking has been shown to decrease biosynthesis of 
these collagens (Knuutinen et al., 2002). Compounding this problem, the inflammation of 
the respiratory passages from smoking results in a chronic cough.  The pairing of poor 
pelvic floor support and sudden increase in intra-abdominal pressure from coughing 
increases the risk of urinary incontinence. 
 Although associated with damage incurred during childbirth or lack of estrogen, 
stress incontinence is not strictly a woman’s disorder. Approximately half of all men who 
undergo radical prostatectomy experience urinary incontinence due to damage to the 
urethral sphincter, presenting with urine loss associated with coughing, sneezing or 
increased physical activity (Abrams, 2003; Yokoyama et al., 2004).  Radical 
prostatectomy patients also experience urine leakage resulting from bladder dysfunction 
in the form of overactive bladder and urge incontinence or a combination of bladder 
dysfunction and sphincter damage. 
 Urge Incontinence. Patients who experience involuntary loss of urine 
accompanying the sensation of a need to void have urge incontinence. Typically, this is 
the result of inappropriate bladder spasms caused by abnormal nerve stimulation  
(de Groat, 1997). 
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Overactive bladder (OAB) is a syndrome which is characterized by urgency, 
frequency and nocturia, and can occur with or without urinary incontinence. The National 
Overactive Bladder Evaluation (NOBLE) program surveyed over 5,000 adults across the 
United States by age, gender and geographic region to determine the prevalence and risk 
factors for OAB.  Data from the NOBLE program show that about one third of all 
patients with OAB experience urinary incontinence.  While both men and women are 
equally affected by OAB, overactive bladder with incontinence is more common among 
women than men, and the prevalence of both forms increases with age (Stewart et al., 
2003).  
Theories related to the pathophysiology of OAB can be described as either 
neurogenic or myogenic.  Damage along nerve pathways can cause bladder over activity 
from uncontrolled voiding reflexes. Stroke or other neurological diseases such as multiple 
sclerosis or Parkinson’s disease are often implicated in overactive bladder of neurogenic 
origin (Porth, 2011).  With myogenic etiology, patients often have bladder outlet 
obstruction with an increase in intravesical pressure. Rather than a normal contraction 
that can empty the bladder, mini-contractions of the detrusor muscle occur resulting in 
overactive bladder symptoms (Wein & Rackley, 2006). 
Certain foods, dyes, chemicals, caffeine in any substance, alcohol and tobacco 
products have all been implicated as irritants to the bladder wall and are associated with 
increased urinary incontinence (Bottomley, 2000). 
Mixed Incontinence. Mixed urinary incontinence is a common finding where 
patients present with urinary leakage associated with both urgency and physical exertion 
(Chu & Domochowski, 2006). Rates of urge and mixed incontinence increase with age, 
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while stress incontinence is not significantly associated with age. This may be due, in 
part, to age-related diseases that can alter normal urinary function (Wallner et al., 2009). 
Other Types of Incontinence.  Other common forms of urinary incontinence 
include overflow and functional incontinence. Overflow incontinence occurs when the 
bladder fails to empty completely, allowing constant dribbling of urine. This can be the 
result of a physical obstruction like a urinary stone or enlarged prostate.  Overflow 
incontinence can also stem from a neurologic abnormality such as a birth defect or spinal 
injury or tumor.  Functional incontinence is most commonly seen in older adults who 
have comorbid or debilitating conditions that may predispose them to urinary 
incontinence by limiting their ability to move quickly enough, or to mentally process 
their need to urinate or communicate that need to caregivers.  
Failure of any aspect of the neuromuscular coordination of micturition can result 
in urinary incontinence.  The causes of overflow and functional incontinence are very 
specific and require management that targets the specific cause.  However, pelvic floor 
weakness, poor vesicourethral support, and detrusor instability are of great interest with 
regard to the application of ExMI because of the potential for this technology to 
strengthen the pelvic floor musculature and reduce detrusor contractility.   
Treatment for Urinary Incontinence 
 Treatment regimens for urinary incontinence vary according to etiology. First, a 
determination of the kind of urinary incontinence is made by obtaining a thorough history 
including food and fluid intake and voiding diaries, as well as physical examination to 
assess for pelvic floor abnormalities. Urodynamic studies may also be performed at this 
time to help determine bladder and urethral function. Once the underlying cause and the 
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severity and type of urinary incontinence is determined, management techniques and 
treatments can begin.  
 Patients are first taught behavioral techniques such as fluid, diet, and bowel 
management, Kegel exercises, and in some cases, scheduled voiding or double voiding.  
Kegel exercises, sometimes referred to as pelvic floor muscle training, helps to strengthen 
and tone the muscles of the pelvic floor and support the urethra so that when there is an 
increase in intraabdominal pressure, as with a cough or sneeze, or the patient experiences 
an involuntary detrusor contraction, he or she can contract the pelvic muscles so that 
urine leakage is prevented (Huebner et al., 2011; Ramundo & Davis, 2002). This training 
must be consistently practiced every day and may take months before any benefit is 
discernible. 
Food/fluid intake diaries and voiding diaries provide valuable information that is 
helpful in assessing voiding patterns and leakage. Many foods can irritate the lining of 
the bladder resulting in pain, bladder spasms, and urinary incontinence. The volume of 
fluid is as important as the types of fluids that patients drink. Drinking excessively as 
well as drinking too little can provoke bladder spasms and leakage. These diaries are 
simple to use and can give the patient, as well as the practitioner, insight into triggers that 
may be causing incontinence. Once the patient has become aware of the relationship 
between intake and incontinence, they can modify their diet to help reduce wetting 
episodes.  
 Bladder innervation and function is very similar to rectal innervation and 
function.  Research has shown that there is a positive correlation between constipation 
and bladder dysfunction (Kim, Lee, Jung, & Lee, 2011). Patients who present with 
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urinary incontinence frequently have chronic constipation (Bannister, Lawrence, Smith, 
Thomas, & Read, 1988) therefore; bowel management is a critical first step in 
conservative treatment of urinary incontinence. Patients are taught how to prevent 
constipation and improve bowel function.  Many find that it does help to reduce 
incontinent episodes.   
Kegel exercises and dietary, fluid and bowel management plans require 
motivation and daily adherence, but can be very effective for some patients. If these 
behavioral management therapies are inadequate, however, more invasive treatment 
regimens may be required and are often used in combination with behavioral techniques.   
The use of a pessary, an intravaginal device that supports the bladder neck, when fitted 
properly can be helpful in preventing stress urinary incontinence in some patients 
(Keyock & Newman, 2011). 
Electrical stimulation has been used successfully for many years to force 
contractions in an effort to strengthen or relax pelvic floor muscles and is often combined 
with biofeedback. However, electrical stimulation of the pelvic floor requires the 
insertion of probes in the vagina or rectum, and it is not well accepted by patients because 
it is invasive and uncomfortable.  Adjusting the frequency (Hertz or Hz) of the electrical 
stimulation allows the practitioner to force contractions that will either strengthen and 
build up muscle or relax muscle. The ability to relax muscle is helpful in patients who 
experience detrusor instability of OAB where the bladder contracts without provocation. 
Relaxing the bladder helps to lessen leaking episodes in patients who have incontinence 
associated with overactive bladder. Electromagnetic stimulation through the use of ExMI 
offers the same results without pain, without probes or embarrassment, making it an 
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attractive alternative. Studies have extrapolated treatment parameters from traditional 
electrical stimulation treatments of the pelvic floor. Frequencies of 5 to 20 Hz have been 
reported to inhibit detrusor contractility (Bradshaw, Barker, Radley, & Chapple, 2003); 
whereas frequencies of 20 to 50 Hz have been reported to increase intraurethral pressure 
which is effective in preventing stress incontinence (Fujishiro et al., 2000; Yamanishi, 
Yasuda, Suda, & Ishikawa, 1999). 
Magnetic Field Therapy. The use of magnets for the treatment of various 
disorders is not a new idea.  They are discussed in ancient Chinese and Egyptian writings 
from as early as 2000 B.C.  Fifteenth century Swiss alchemist, Paracelsus investigated the 
use of magnets to heal illness (Macklis, 1993) by restoring the body’s natural energy 
(Philpott & Kalita, 2000).  Eighteenth century physician and astrologer, Franz Mesmer 
believed in an energy that flowed through the body that he called animal magnetism 
(Macklis, 1993).  Both Paracelsus and Mesmer treated individuals by passing magnetized 
stones called lodestones over the bodies of those seeking to be healed (Philpott & Kalita, 
2000). For centuries, magnets were widely used to treat illness and restore health, but as 
medicine became more grounded in scientific evidence and therapeutic regimens 
included effective medications, the use of magnet therapy began to wane.  For most of 
the twentieth century, magnets were viewed with skepticism and associated with 
quackery (Philpott & Kalita, 2000). 
While there have been anecdotal reports that static magnets have been helpful in 
treating various medical conditions, there is little clinical or experimental data to support 
these claims. On the other hand, the use of magnetic energy is readily accepted by both 
the medical community and general public for diagnostic imaging with MRI (Lalande et 
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al., 2004).  Pulsed electromagnetic field therapy has been reported to help a wide variety 
of medical conditions including bone healing (Garland, Adkins, Matsuno, & Stewart, 
1999; Kumar et al., 2005; MacKenzie & Veninga, 2004; Massari, Fini, Cadossi, Setti, & 
Traina, 2006), and soft tissue healing (Kenkre, Hobbs, Carter, Holder, & Holmes, 1996; 
Strauch et al., 2006; Yamaguchi, Ogiue-Ikeda, Sekino, & Ueno, 2006).  This technology 
has also been shown to affect neural tissue (Goodwin, 2003; Mert, Gunay, Gocmen, 
Kaya, & Polat, 2006), ease pain (Lyskov et al., 2005; Pipitone & Scott, 2001; Shupak et 
al., 2006; Weintraub & Cole, 2004, relieve mental depression (Baeken et al., 2009; 
Fitzgerald, Hoy, Daskalakis, & Kulkarni, 2009; Vanderhasselt, DeRaedt, Leyman, & 
Baeken, 2009) and help individuals with urinary and fecal incontinence (Galloway et al., 
1999; Thornton, Kennedy, & Lubowski, 2005; Yokoyama et al., 2004; Yokoyama et al., 
2005). 
 Pulsed Electromagnetic Fields. The application of a pulsed electromagnetic field 
is a non-traditional, non-invasive form of energy medicine that is gaining popularity in 
healthcare today.   The application of a magnetic field is thought to be beneficial by 
positively affecting physiological processes. Magnetic therapies can be further divided 
based on whether a static magnet or pulsing electromagnet is used. A static magnet is one 
that creates a field that moves in a steady flow.  An electromagnet can reverse direction 
generating a pulsed electromagnetic field when turned off and on rapidly.   
 The therapeutic application of pulsed electromagnetic fields is based on Faraday’s 
Law of Magnetic Induction which asserts that a changing magnetic field will produce 
electrical current in adjacent tissues (Walker, 2004). When the changing magnetic field is 
generated near living tissue, electrical currents induced within the tissues cause 
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depolarization in motor nerves. The ensuing nerve impulse stimulates the release of 
acetylcholine, depolarization of muscle fibers and muscle contraction (Galloway, El-
Galley, Sand, Appel, Russell, & Carlan, 1998; Hoscan, et al., 2008; Voorham-Van der 
Zalm, Pelger, Stiggelbout, Elzevier, & Lycklama A Nijeholt, 2006). No electric current 
actually enters the body. The magnetic field is indifferent to tissue impedance.  With no 
opposition, the magnetic field encounters no obstruction from clothing or human tissue. 
Patients who receive pulsed electromagnetic field therapy targeting the pelvic floor 
muscles do not need to undress.  There is no need for probes or insertion of internal 
devices. They sit, fully clothed, on a chair with the electromagnet imbedded within the 
seat. When the electromagnet is engaged, the pulsing magnetic field painlessly induces 
contractions of the pelvic floor and sphincter muscles (Chandi, Groenendijk, & Venema, 
2003; Doganay, Kilic, & Yilmaz, 2010).  Termed extracorporeal magnetic innervation 
(ExMI), this forced exercise of the pelvic floor serves to build endurance and strengthen 
the muscles supporting the bladder during times of physical stress such as coughing, 
sneezing or increased physical activity.  Another advantage of this treatment is based on 
the fact that magnetic stimulation of sacral nerve roots is insufficient to induce bladder 
contractions.  Studies have demonstrated that when magnetic stimulation is applied, 
bladder contractions are inhibited, suppressing detrusor instability in patients with urge 
incontinence (Bradshaw, Barker, Radley, & Chapple, 2003; Bycroft, Craggs, Sheriff, 
Knight, & Shah, 2004; Voorham-VanDerZalm, Pelger, Stiggelbout, Elzevier, & 
Lycklama A Nijeholt, 2006).   
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Summary 
 The purpose of this study was to evaluate the clinical outcomes involving the use 
of pulsed electromagnetic fields in the treatment of urinary incontinence. This study is 
based on scientific concepts including the physiology of micturition and the science of 
pulsed electromagnetic fields.  The use of pulsed electromagnetic fields in the treatment 
of urinary incontinence is relatively new and there is little in the literature with regard to 
this therapy’s efficacy and long-term effects. This study will add to that body of 
knowledge related to the effectiveness of ExMI.
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CHAPTER II 
 
REVIEW OF THE LITERATURE 
 The application of pulsed electromagnetic fields has been used for treating a 
number of disorders that range from bone and tissue healing to the treatment of 
incontinence. This chapter presents an overview of literature related to the effects of 
pulsed electromagnetic fields on biological tissues, and includes information on how this 
technology has been studied as a modality to treat a variety of conditions including 
urinary incontinence. 
Stress Urinary Incontinence 
 Galloway, El-Galley, Sand, Appell, Russell, and Carlan (1999) reported using 
pulsed electromagnetic field stimulation to treat stress urinary incontinence in women.  
Participants completed 3-day bladder diaries in which they recorded their voided 
volumes, the number of leaks they experienced each day, and the number of pads they 
used in a day.  They also had a standardized pad weight test and urodynamic study to 
assess the severity of their leakage.  Additionally, all women completed a quality of life 
survey.  A total of 83 females with stress urinary incontinence were exposed to the pulsed 
field by sitting on a chair that had been fitted with an electromagnet under the seat.  This 
particular piece of equipment is called the Neocontrol System by Neotonus, and has been 
FDA approved for the treatment of stress urinary incontinence in women (Galloway et 
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al., 1999).  The therapy has been named ExMI for extracorporeal magnetic innervation. 
The women were completely clothed and seated on the chair so that the perineum was 
centered and the pelvic floor muscles were in the direct line of the magnetic field. 
Treatments were given twice a week for six weeks.  They included ten minutes of pulsed 
stimulation at 5 Hz, a 1 to 5 minute rest period, and then ten minutes of pulsed 
stimulation at 50 Hz.  Every two weeks the patients kept a three-day bladder diary.  Two 
weeks after the end of the study, all women repeated all baseline studies.  At week 12, the 
bladder diary and quality of life survey only were repeated. There were 50 women at 
follow-up in 3 months. The reduction in pad use was significant (p=0.001) from baseline 
to completion of treatment, as was the reduction in frequency of leaking episodes 
(p=0.001).  Mean bladder capacity was unchanged.  Detrusor instability had been 
demonstrated in five patients during urodynamic examination at baseline, but only in one 
patient after treatment.  This is of interest because detrusor instability is associated with 
involuntary bladder contraction either spontaneously or on provocation (Chapple & 
Christmas, 1992) which results in urge incontinence.  
 A study by Hoscan et al. (2008) evaluated the long-term efficacy of 
electromagnetic stimulation for stress incontinence.  Thirty subjects completed bladder 
diaries, pad weight tests, urodynamics and quality of life surveys prior to receiving 
treatment sessions lasting 20 minutes, twice a week, for six weeks. They received the 
same protocol as previously discussed studies with frequencies of 5 and 50 Hz 
intermittently for 10 minutes. Follow-up was performed at 3, 12, and 24 months after 
treatment.  At 3 months, the cumulative success rate was 77.8% with only six subjects not 
showing any improvement in symptoms. After one year, researchers report the effect of 
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electromagnetic stimulation gradually decreased until subjects’ symptoms were near 
baseline at the 24 month follow-up. They concluded that while this therapy offers an 
effective modality for urinary incontinence that is painless and non-invasive, more 
studies need to be done to determine how long benefits would last and when retreatment 
would provide the best outcome.  
Bakar, Ozdemir, Ozengin, & Duran (2010) explored the efficacy of ExMI for 
older women who were diagnosed with stress urinary incontinence.  Thirteen patients 
between the ages of 61 and 69 (mean 65.23 + 2.8 years) participated in this study.  
Urinary symptoms, pelvic floor electromyographic activity (EMG), pad testing and 
Quality of Life (QOL) were evaluated at baseline and at six weeks.  Pad test results 
showed significant reduction in urine loss (p=0.016), significant improvement in EMG 
values (p=0.005) and in QOL scores (p=0.002).  This study suggests that ExMI could be 
a viable treatment alternative for older women who do not wish to have definitive 
surgical intervention or who might not be good surgical candidates.  
 Ismail, Forward, Bastin, Wareham, Emery, & Lucas (2009) conducted a 
prospective, non-controlled study specifically to assess efficacy, side effects, and dropout 
rates for women treated with ExMI for stress urinary incontinence.  Forty-eight patients 
were recruited and outcome measures of pad weight test, daily pad use, daily leaking 
episodes and quality of life were evaluated.  Thirty-one patients completed eight weeks of 
twice weekly treatments.  Twenty-seven patients returned at the three month re-
evaluation.  This study revealed no significant differences in outcomes for pad weight, 
pad use, leaking episodes or quality of life from beginning to end of treatment or at the 
three month reassessment.  When asked about side effects the majority of patients 
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(62.7%) cited various types of pain. Eight percent of patients who dropped out of the 
study cited various types of pain, and 15% of dropouts gave no reason.  This study is 
unique in that it looks at side effects and dropout rates, something that has not been found 
in other studies. 
Detrusor Instability with Incontinence (Urge) 
 Choe, Choo, & Lee (2007) studied forty eight women with detrusor instability 
using the Neocontrol chair and the same protocol as in previous studies. They reevaluated 
these subjects at 2, 12, and 24 weeks post treatment and found that subjects’ perception 
of treatment benefit and overall satisfaction was 68.8% and 66.7% at week 2, 58.3% and 
54.2% at week 12, and 54.2% and 52.1% at week 24.  Their study demonstrated that 
electromagnetic stimulation therapy has a beneficial effect that can be sustained for an 
extended period of time in persons with detrusor instability.   
Mixed Urinary Incontinence 
  Yamanishi et al. (2000) conducted a pilot research study and a therapeutic study 
to evaluate efficacy of pulsed electromagnetic stimulation on urethral closure and bladder 
inhibition.  The pilot study consisted of 11 subjects with stress incontinence and 11 
subjects with urge incontinence.  The urethral pressure differences between on and off 
phases of electromagnetic stimulation showed that maximum urethral closure pressure 
significantly increased (p=0.0409) after stimulation for subjects with stress incontinence.  
Also, there was a statistically significant increase in bladder capacity at first desire to 
void (p=0.0164) and maximum desire to void (p=0.0208) during stimulation for subjects 
with urge incontinence.  
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In the therapeutic arm, 15 subjects, seven with stress incontinence and eight with 
urge incontinence were studied.  Urodynamic testing was performed on each subject 
before and after a five week treatment regimen with the electromagnetic stimulation. 
These subjects recorded frequencies of voiding, leaking, degrees of urgency, pad changes 
as well as their perceptions of the therapy and their quality of life scores.  At the end of 
the study, six of the subjects with stress incontinence and six of the subjects with urge 
incontinence indicated that they were either cured or had significant improvement in their 
symptoms. Quality of life scores were significantly improved after the treatment regimen 
(p=0.0033) with most respondents reporting that they were delighted or mostly satisfied 
with their overall quality of life. 
These researchers assert that although the outcomes of electromagnetic 
stimulation are similar to those of electrical stimulation of the pelvic floor, 
electromagnetic stimulation is superior due to the fact that it does not cause pain and it is 
noninvasive. 
Unsal, Saglam, and Cimentepe (2003) looked at one year follow-up for patients 
who had received ExMI for both stress and urge incontinence.  The researchers evaluated 
clinical outcomes by voiding diary documentation of leaking episodes and pad weight as 
well as increase in mean valsalva leak point pressure in patients who had stress 
incontinence. At the one year follow-up, patients who reported no leaking episodes and 
less than 1 gram urine in pad weight test were documented as cured.  Patients who 
reported greater than 50% in reduction of leaking episodes and pad weight tests were 
documented as improvement. They began with a total of 57 female patients.  Of these 
patients, 35 were diagnosed with stress and 17 with urge incontinence.  Forty-four 
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patients completed treatments and returned for follow up in one year.  Of the 44 patients, 
11 (38%) with stress and 6 (41%) with urge were deemed cured. In addition, there was an 
improvement in symptoms in 12 patients (41%) in the stress group and 7 (47%) in the 
urge group. Pad weight was reduced from 15.4 to 5.8 g in the stress group and from 12.4 
to 4.7 g in the urge group (p = 0.000 and 0.001, respectively). Mean Valsalva leak point 
pressure was increased from 87.3 + 15.9 to 118.0 + 11.0 cmH2O in the stress group  
(p = 0.000). 
 Yokoyama et al. (2004) conducted an almost identical study as the one by 
Galloway et al. (1999) however; they were interested in exploring whether this therapy 
would be effective in treating urge incontinence. These researchers used the same 
Neocontrol System chair in their study. Twenty patients with urge incontinence and 
seventeen patients with stress urinary incontinence were recruited for this study and 
although the results were not as dramatic as for stress incontinence alone, episodes of 
leaking were reduced from 5.6 times per day before treatment to 1.9 times per day at 8 
weeks (p<0.05) and the mean pad weight was reduced from 7.9 g at baseline to 1.9 g at 8 
weeks (p<0.05). Twenty-four weeks after the last treatment, eight patients with urge 
incontinence and three with stress incontinence experienced recurrence. 
Almeida, Bruschini, and Srougi (2004) studied 91 women using the Neocontrol 
chair.  These subjects were treated for 20 minutes twice a week for eight weeks. The 
treatment protocol consisted of 10 minutes of intermittent low frequency stimulation for 5 
seconds at 5 Hz and 5 seconds off, then 10 minutes of intermittent high frequency 
stimulation for 5 seconds at 50 Hz and 5 seconds off.  The researchers note that subjects 
experienced significant improvement midway through the study.  By the end of the study, 
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they report 34 of the 91 were totally dry with no leaking episodes.  These subjects were 
followed by interview at 3, 6, and 12 months after the study. The recurrence rate was 
high at 47%, 61.7%, and 94% respectively. These researchers conclude that the 16 
sessions are not adequate for long-term success since the benefits were temporary with 
high and early recurrence rates. 
 Doganay, Kilic, & Yilmaz (2009) evaluated the long term efficacy of ExMI over 
three years. They followed a similar protocol as Unsal, Saglam, & Cimentepe in 2003, 
but they added number of pads used daily and Quality of Life (QOL) score as part of 
their evaluation of clinical outcomes.  In the stress incontinence group, there was a 
significant reduction in pad use between the baseline (3.2 + 1.6) to first (2.4 + 1.2), 
second (2.9 + 1.17), and third (3.0 + 1.1) year follow-ups (P < 0.001, P > 0.05, P>0.05, 
respectively). There was no difference in pad use between the second and third year 
follow-ups. In the urge incontinence group where baseline daily pad use was  
3.7 + 1.9, the numbers at first, second, and third years were 2.4 + 1.3, 3.1 + 1.8, and 3.3 + 
2.4, respectively.  Quality of Life scores for patients with stress incontinence improved 
from baseline 62.5 to 88.7 at eight weeks which was significant (p=0.001).  Quality of 
Life scores for patients with urge incontinence saw a similar improvement from baseline 
at 60.8 to 86.3 at eight weeks (p=0.001).  Patients were evaluated at 12, 24, and 36 month 
intervals.  The effects of ExMI and QOL scores gradually decreased and were close to 
baseline at the 3rd year mark.  This suggests that ExMI can provide temporary relief from 
urinary incontinence and short-term improvement in quality of life and patient 
satisfaction.  More understanding of how to extend the benefits of this treatment is 
needed.   
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Lo, Tseng, Lin, Liang, Lu, and Pue (2013) conducted a retrospective review of 93 
patients with stress urinary incontinence and overactive bladder (OAB) who were treated 
with ExMI.  Results revealed that 72 patients (77%) completed a 9 week protocol of 10 
Hz followed by 50 Hz.  Thirty-two of 34 patients (94%) experienced improvement for 
OAB and 33 of 38 patients (86.8%) experienced improvement of for stress urinary 
incontinence. Urogenital Distress scores and Quality of Life scores improved for both 
groups.  Researchers cite cost of treatment and geographic location as reasons for the 
high dropout rate among patients. 
Post Prostatectomy Incontinence 
 A study to compare the effect of pulsed electromagnetic stimulation and electrical 
stimulation on urinary incontinence in patients who had retropubic radical prostatectomy 
(Yokoyama et al., 2004) showed rapid improvement in symptoms with both methods. 
Subjects were randomly assigned to receive electrical stimulation, electromagnetic 
stimulation, or be in the control group.  The electromagnetic stimulation protocol was the 
same as used in previous studies employing the Neocontrol system.  The electrical 
stimulation protocol used an anal electrode that delivered stimulation at parameters 
consistent with electrical stimulation standards for urinary incontinence therapy (Barroso, 
Ramos, Martins-Costa, Sanches, & Muller, 2005; Moore, Griffiths, & Hughton, 1999; 
Nakagawa et al., 2010). The control group only performed pelvic floor muscle exercises. 
After one month, the control group showed slight improvement over electromagnetic or 
electrical stimulation groups, but by the second month there was a statistically significant 
decrease in incontinence volume in both treatment groups. The researchers consider both 
29 
 
 
 
methods to be viable, recommendable options for patients who seek improvement of 
urinary incontinence after radical prostatectomy.  
 Yokoyama et al. (2005) investigated the effects of pulsed electromagnetic field 
stimulation on urinary incontinence after retro-pubic radical prostatectomy.  Ten men 
who had suffered from urinary incontinence for at least 12 months post radical 
prostatectomy were enrolled into the study.  Urodynamic studies were performed at 
baseline and again at the completion of treatment. The researchers used the same 
Neocontrol System as in previous studies to induce the pulsed electromagnetic field.  
Patients received treatments for 20 minutes, twice a week for two months. The pulsed 
field was set at 10 Hz for 10 minutes, then at 50 Hz for 10 minutes. Bladder diaries, pad 
weight testing and quality of life surveys were obtained at one, two, three, and six months 
after the start of treatment. Results showed that three patients became dry (30%), three 
patients showed improvement (30%), and 4 patients showed no change (40%). Mean pad 
weight decreased from 25 g to 10.3 g, and the quality of life scores improved from 70.5 
to 84.9.  The frequency of leak episodes in a day was reduced from five times prior to the 
treatment to 1.9 times after the treatment.  Three of six patients who showed 
improvement, however, did return to baseline values within a year of treatment, and 
requested to be allowed to continue the treatment. 
 Terzoni, Montanari, Mora, Ricci, and Destrebecq (2012) compared pelvic floor 
muscle exercises (PFME) and ExMI for the management of post-prostatectomy urinary 
incontinence.  Eighty seven patients were treated with PFME, 23 patients were treated 
with ExMI, and 22 patients refused intervention and served as the control group.  Both 
interventions improved scores on the International Prostate Symptom survey and ExMI 
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demonstrated faster reduction in symptoms than PFME.  Most of these researchers were 
rehabilitation nurses and they proposed that ExMI could be an effective treatment 
administered and managed by nurses.  They suggest that ExMI could be used to quickly 
increase pelvic floor muscle strength and that PFME could be used to help patients 
maintain that level. 
Fecal Incontinence 
 Thornton, Kennedy, & Lubowski (2005) conducted a study to determine the 
effect of pulsed electromagnetic stimulation on anorectal function and physiology. They 
studied ten subjects with fecal incontinence, and compared those findings with five 
subjects who were continent.  Subjects received pulsed electromagnetic stimulation by 
sitting in the Neocontrol Chair as discussed in previous studies.  The protocol of 10 Hz 
for 10 minutes followed by 50 Hz for 10 minutes was followed for this study.  The results 
revealed that stimulated anal pressures were significantly increased when compared to 
resting pressures (p=0.005).  After six weeks of treatment, there was a statistically 
significant increase in resting pressures (p=0.007), in squeeze anal pressures (p=0.008), 
and a decrease in continence scores (p=0.017).  Although statistically significant, there 
was only a small increase in the subjects’ perceived improvement after six weeks of 
treatment. 
 Studies examining pulsed electromagnetic fields effects on pelvic muscles for 
urinary and fecal incontinence suggest that this technology can be beneficial to patients 
who have voiding and anorectal dysfunction.  More research is needed to determine who 
will benefit the most from this therapy, as well as optimal settings and timing duration of 
treatment. 
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Bone and Tissue Healing 
 Garland, Adkins, Matsuno, and Stewart (1999) examined the effects of pulsed 
electromagnetic fields on osteoporotic bone at the knees of six males with spinal cord 
injury.  Bone density of both knees was assessed at baseline, 3, 6, and 12 months.  One 
knee was stimulated with a pulsed electromagnetic field while the other knee served as 
the control.  Electromagnetic stimulation was conducted for a period of six months. At 
three months, during the middle of the treatment period,  bone density  increased in the 
knees that  received the stimulation by 5.1%, but declined in the knees that served as 
control by 6.6% (significant at p<.05 and p<.02, respectively).  At six months, bone 
density had returned to near baseline and at 12 months both knees had lost bone density 
with the stimulated knees being 2.4 % below baseline, and the control knees being 3.6% 
below baseline.  This would suggest that pulsed electromagnetic field therapy could be 
helpful in slowing down the progression of osteoporosis, but raises questions about the 
length of time needed to obtain therapeutic effects and how long positive effects can be 
sustained once treatment has ended. 
In a study by Massari, Fini, Cadossi, Setti, and Traina (2006) 66 patients (a total 
of 76 hips) with early to late osteonecrosis of the femoral head were treated with pulsed 
electromagnetic field stimulation for eight hours a day over a period of five months. 
Although the researchers considered whether or not the patients were able to avoid hip 
replacement surgery to be the ultimate goal of this study, they also compared diagnostic 
images taken of the hips at the beginning of the study and at the time of follow-up.  
While fifteen hips did require total hip replacement, the number of patients not requiring 
hip replacement was significant. All patients were experiencing pain when they entered 
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the study, but by the sixtieth day of treatment, thirty-five patients declared that they were 
pain free.  Another seventeen patients admitted that pain was only of moderate intensity.  
The researchers concluded that pulsed electromagnetic field stimulation may help to 
protect the cartilage and bone by reducing inflammation and edema.  They hypothesized 
that long-term use might actually stimulate bone growth where it is necrotic, thereby 
preventing fracture and bone collapse.  However, this hypothesis has yet to be tested in 
humans. 
 MacKenzie and Veniga (2004) report in a case study how pulsed electromagnetic 
field stimulation was successfully used to reverse delayed union of an anterior cervical 
fusion.  Their patient was a 43 year old female who presented with complaints of a 
clicking noise when turning her head, difficulty swallowing and a feeling of choking at 
times.  She also complained of shooting pains from her neck to her lower back and 
numbness in her upper arms and hands.  An MRI revealed severe disc degeneration from 
C5 through C7.  They performed surgery by removing the diseased disks and placed 
allograft bone dowels in the C5-C6 and C6-C7 interspaces secured with an anterior 
fixation plate.  This patient reportedly had an uneventful recovery and was asymptomatic 
for about six months.  At her one year postoperative visit she complained of an ache in 
her neck that had been getting worse over the past 6 months.  X-rays were obtained and 
revealed that while bone had formed around the C5-C6 level, the bone graft had failed at 
the C6-C7 level. Rather than return to surgery, the patient chose to wear a pulsed 
electromagnetic field stimulator for three hours every day for ten months.  After three 
months, the neck pain had completely resolved, and X-rays taken after fifteen weeks of 
stimulation revealed that fusion of the bone graft at the C6-C7 level was beginning to 
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take place.  At the end of treatment, diagnostic imaging showed solid bone formation at 
the C6-C7 level.  MacKenzie and Veninga also reported that at the time of their published 
case study, which was thirteen months post-treatment, the patient was still asymptomatic 
and pain free. 
 Kenkre, Hobbs, Carter, Holder, and Holmes (1996) studied electromagnetic 
therapy as an adjunct to conventional compression dressings in venous leg ulcers.  Their 
study was a randomized, double blind clinical trial with nineteen patients who had been 
diagnosed with venous leg ulcers.  They looked at several outcomes including the rate 
and scale of wound healing, quality of life, reported pain levels, and degree of mobility. 
Patients were randomly assigned to either the active treatment or placebo groups. Active 
treatment groups received pulsed electromagnetic stimulation at either 600Hz or 800Hz.  
A machine that was indistinguishable from the actual stimulator was used for placebo 
treatment.  Patients received 30 minute treatments for 30 days.  Upon completion, they 
were observed and received the standard compression dressing changes only for the next 
four weeks.  They were assessed on treatment days 1, 5, 20, and 30 and a final 
assessment was performed on day 50.  The researchers found that the majority of patients 
(68%) reported improvement in the size of their ulcers, with 21% of the patients 
experiencing complete healing.  Relief of pain during the trial was significant (p<0.05).  
Patients who received treatment at 800Hz experienced significant healing (p<0.05) when 
compared to either the placebo group or the active group that received treatment at 
600Hz. 
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Perception of Pain 
 Lyskov et al. (2005) conducted a study on the effect of pulsed electromagnetic 
fields on reported pain level, heart rate, and blood pressure in 24 healthy volunteers.  This 
was a double blind, crossover design study where the subjects served as their own 
controls. Twelve males and 12 females each received infusions of 5% hypotonic saline 
solution into the erector spinae muscle to induce muscle pain.  This experiment was 
performed twice, at least two days apart.  One time the subject was exposed to the pulsed 
field, and one time to a sham field.  Results revealed that blood pressure elevation due to 
pain occurred during both active and sham exposures, and there was no statistical 
difference for heart rate.  The study did, however, demonstrate gender differences as 
exposure to the pulsed field increased the subjective pain levels in females, but not in 
males. This has implications for future investigations into the use of pulsed 
electromagnetic fields for the treatment of chronic pain especially with regard to gender 
differences in the perception of pain. 
 Pipitone and Scott (2001) performed a randomized, placebo-controlled, double-
blind study on the effect of pulsed electromagnetic field therapy with 75 patients with 
osteoarthritis of the knee.  Patients completed the WOMAC Osteoarthritis Index and the 
EuroQoL (EQ-5D) at baseline and again after treatment to assess pain, joint stiffness, 
disability, and quality of life.  There were significant improvements in the actively treated 
group on the WOMAC global score (p=0.018), WOMAC pain score (p=0.065), 
WOMAC disability score (p=0.019), and EQ-5D quality of life score (p=0.001).  These 
results suggest that pulsed electromagnetic field therapy could be beneficial in improving 
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quality of life by reducing pain and disability for patients who suffer with osteoarthritis of 
the knee.  
 Weintraub and Cole (2004) used a one-group experimental design study to 
examine the effect of pulsed electromagnetic fields on refractory neuropathic foot pain in 
24 patients who had been diagnosed with peripheral neuropathy.  Among these patients, 
the one with the most symptomatic foot received nine daily 1-hour treatments with 
exposure to the pulsed electromagnetic field at 30Hz.  All 24 patients (24 feet) completed 
the 9 day study and 15 of the 24 completed follow-up.  Mean pain scores decreased 21% 
from baseline to end of treatment (p=0.19), but there was a 49% reduction in pain from 
baseline to follow-up which was significant (p<0.01). This study suggests that pulsed 
electromagnetic field therapy could be useful in providing pain relief for persons 
suffering with neuropathic pain. 
 Shupak, McKay, Nielson, Rollman, Prato, and Thomas (2006) investigated the 
use of pulsed electromagnetic fields on pain and anxiety in patients with fibromyalgia 
and rheumatoid arthritis. The researchers used a double blind, randomized, placebo-
controlled design.  Eighteen patients had fibromyalgia, and 13 patients had rheumatoid 
arthritis.  They received either the pulsed electromagnetic field therapy or sham exposure. 
The results revealed that there was no significant reduction in anxiety ratings for either 
group. However, there was significant (p<0.05) reduction in pain for the patients who had 
rheumatoid arthritis, and significant (p<0.01) reduction in pain for patients who had 
fibromyalgia when they were exposed to the active therapy. 
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Mental Depression 
 Pulsed electromagnetic fields have most recently been investigated for treatment 
of resistant mental depression.  Baeken et al. (2009) studied a small group of subjects 
who had been diagnosed with treatment-resistant depression.  All subjects were free of 
antidepressant and psychotropic medication prior to and during the study.  A psychiatrist 
rated the subjects’ depression symptoms and depression severity before and after 
application of transcranial magnetic stimulation. Forty-three percent of the subjects 
experienced a reduction of at least 50% of their depression scores. 
 A study by Fitzgerald, Hoy, Daskalakis, and Kulkarni (2009) examined the 
differences between the application of high frequency transcranial magnetic stimulation 
and low frequency transcranial magnetic stimulation.  They determined that both 
treatment groups showed significant improvements in their depression and there were no 
significant differences between the use of high or low frequencies. This is an important 
study because there have been very few investigations that compare the efficacy of the 
two methods.   
 Vanderhasselt, DeRaedt, Leyman, and Baeken (2009) discovered similar effects 
when depressive symptoms improved in more than half of their therapy-resistant subjects 
after receiving transcranial magnetic stimulation.   
 There is much conjecture as to how transcranial application of pulsed 
electromagnetic fields improves mental depression. It has been suggested that it works by 
triggering action potentials which cause the neurotransmitters dopamine and serotonin to 
be released.  Researchers have theorized that the magnetic stimulation alters cerebral 
blood flow as well as improves mood by altering brain waves (Baeken et al., 2009; 
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Huerta & Volpe, 2009). Results of preliminary studies are promising, but more research 
is needed. 
Summary 
 Pulsed electromagnetic field therapy is a painless, non-traditional, non-invasive 
modality that holds incredible promise for patients who have not responded to traditional 
treatment methods or who may not be good candidates for surgery or other medical 
procedures.  Currently FDA approved for the treatment of stress urinary incontinence and 
muscle rehabilitation, studies suggest that this technology can stimulate cell growth, 
improve peripheral perfusion and reduce pain. Because this is a relatively new area of 
medicine, there is not a large body of information available. Reported results are varied 
and there is little data on the long term effects of pulsed electromagnetic field therapies. 
More research is needed to add to the knowledge base of electromagnetic stimulation as a 
treatment modality. 
 
 
 
 
CHAPTER III 
METHODOLOGY 
 This chapter describes the methodology that was used in this study. Purpose, 
objectives, design, sample, data collection, and data analysis are discussed. 
Study Design 
 This study is a descriptive, retrospective analysis of data collected from a 
specialty continence center within a major Atlanta metropolitan outpatient facility.  All 
patients who were treated with extracorporeal magnetic innervation (ExMI) from 2000 
through 2012 were included. Sample size was projected to include 75 to 100 patients; 
however the sample size was much smaller with a total of 43 patients who received 
ExMI.  The purpose of this study is to examine the demographic, clinical and behavioral 
factors that support the effectiveness of ExMI treatment for patients with urinary 
incontinence.  The following objectives are explored:   
1. Examine the differences in selected demographics (age in years, gender, 
weight in pounds) and relationship among health behaviors (dietary/fluid 
management, bowel management), medications (diuretics, central nervous 
system [CNS] depressants, hormones, anticholinergics, antihistamines, others 
as appropriate to bladder function), physical findings (cystocele, rectocele, 
uterine prolapse, vaginal/rectal tone/grip), medical history (length of 
incontinence, pelvic surgery, cardiovascular disease, hypertension, diabetes, 
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neurologic disorders, stroke, COPD/asthma, bladder/kidney infections, 
pelvic/abdominal/back pain, pregnancies, methods of delivery, and number of 
pads used per day prior to treatment), between patients with stress, urge, and 
mixed urinary incontinence. 
2. Explore the relationship of selected demographics (age in years, gender, 
weight in pounds) and health behaviors (dietary/fluid management, bowel 
management), medications (diuretics, central nervous system  [CNS] 
depressants, hormones, anticholinergics, antihistamines, others as appropriate 
to bladder function),  physical findings (cystocele, rectocele, uterine prolapse, 
vaginal/rectal tone/grip), medical history (length of incontinence, pelvic 
surgery, cardiovascular disease, hypertension, diabetes, neurologic disorders, 
stroke, COPD/asthma, bladder/kidney infections, pelvic/abdominal/back pain, 
pregnancies, methods of delivery, and number of pads used per day prior to 
treatment), and post-treatment pad usage following ExMI treatment for 
urinary incontinence. 
3. Describe the patients who returned for additional ExMI treatments. 
4.   Describe any benefits received unrelated to reduction of urinary incontinence. 
Sample  
 Data was collected on all patients who received treatment with ExMI at this 
center from 2000 through 2012 totaling 43 patients.  These patients were diagnosed with 
stress, urge, or mixed urinary incontinence as well as fecal incontinence, pelvic pain and 
urinary frequency and urgency.  Data from both female and male patients who received 
ExMI was collected, however, the number of females was higher than males.  This was 
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expected since, statistically, urinary incontinence is more prevalent among middle aged 
and older adult females than among males (Huang et al., 2006; Melville, Katon, Delaney, 
& Newton, 2005).  Exclusion criteria for this treatment included pregnancy, diagnosis of 
pelvic cancers, and having a cardiac pacemaker or other implanted metal device.  Due to 
the overall small number, manual medical record chart review was performed in order to 
capture all patients who had completed this treatment.  
 An online power analysis (Soper, 2012) using a maximum of eleven variables, a 
medium effect size, alpha of <0.05 and power of 0.80 determined that a minimum sample 
size of 122 patients will be needed.  As previously stated, this is a fixed sample size 
predetermined by the number of patients at this site who were treated with ExMI.  Not all 
independent variables are expected to have a significant relationship to the dependent 
variable, and so it is anticipated that the number of variables actually entered into the 
analysis model will be less. A statistical consultation and adjustment will be made as 
necessary to support the power of the findings. 
Site 
Study data was obtained from patient records of a specialty continence center 
within a major Atlanta metropolitan outpatient facility. This center manages about 2000 
patients a year who are diagnosed with incontinence.  There are differing data in the 
literature regarding the prevalence of urinary incontinence among the general population. 
According to the National Association for Continence (NAFC), women comprise 
approximately 75%-80% of the population who suffer with urinary incontinence (NAFC 
facts and statistics) while Melville, Katon, Delaney, and Newton (2005) report that 45% 
of the population who have some form of urinary incontinence are women.  
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Approximately 75% of the patients treated for urinary incontinence within this center are 
women and approximately 25% are men. 
IRB Approval 
Dr. Niall Galloway, MD, is the medical provider for these patients and primary 
prescriber of ExMI treatment.  He has been involved with original research related to the 
use of ExMI for urinary incontinence and has granted permission for the use of the data 
(Galloway et al., 1999). Letters of support from the medical center’s Institutional Review 
Board ( IRB) and Dr. Niall Galloway granting permission to access records and perform 
research at the center pending IRB approval can be found in Appendices A and B 
respectively. The study received approval from Georgia State University’s IRB. The IRB 
at the medical center where data was obtained deemed that IRB approval was not 
required since the study did not meet the definition of research with “human subjects” 
(Appendix C). 
ExMI Treatment Protocol 
 Patients sit fully clothed on a chair designed with a magnetic field generator 
imbedded in the seat.  This generator is connected to an external power control panel that 
controls the pulse current that the patient receives. The practitioner who administers the 
treatment can either manually adjust the amplitude and strength of the magnetic field, or 
as in most cases, insert a “smart card” into the control panel. The control panel reads the 
prescription imbedded in the “smart card” and automatically administers the treatment to 
the patient.  The standard treatment protocol prescription administers 10 minutes of 
intermittent low-frequency stimulation (15 Hz), followed by rest (no stimulation) for 2 
minutes, and ends with 10 minutes of intermittent high-frequency stimulation (40 Hz).  
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These treatments are administered twice a week for 8 weeks (Galloway et al., 1999; 
Hoscan et al., 2008). 
 There is little in the literature related specifically to ExMI therapy, but among 
these studies, there is varied information regarding side effects.  Some studies have 
reported that patients complained of pain, tingling, abdominal cramping and muscle 
fatigue after receiving stimulation (Groenendijk et al., 2008; Ismail et al., 2009) while 
other studies report no complaints of discomfort (Galloway et al., 1999; Hoscan et al., 
2006; Yamanishi et al., 2000).  Only one study cited reasons for dropping out. These 
reasons included pain, urinary tract infection, no improvement and inability to keep 
appointments (Ismail et al., 2009). Given the fact that the treatment is administered twice 
a week for eight weeks, the time commitment and ability to travel to the clinical site 
could certainly have an impact on the dropout rate. 
Measures 
The following variables were obtained from the medical records and used to 
explore the relationship between demographics, medical history, health behaviors, 
physical findings, and clinical outcomes.  The information was transferred to a data 
collection sheet designed for this purpose (Appendix D).  This investigator collected the 
data while at the center and under the supervision of Dr. Galloway.  No patient identifiers 
were on the data collection sheets. 
 Demographics.  The following are categorized as demographics: age in years, 
gender, and weight in pounds.  These characteristics are important because the literature 
points to a relationship between age, gender, and weight and the prevalence of urinary 
incontinence.  Women are more likely to suffer from urinary incontinence than men 
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(Keyock & Newman, 2011).  Excess weight strains the muscles of the pelvic floor 
(Smith, 2004).  In longitudinal, population based studies, obesity has been associated 
with increased incidence of urinary incontinence (Subak, Richter, & Hunskaar, 2009).   
 Medical History.  The health information relevant to a medical history for 
patients with urinary incontinence include the following: length of incontinence, 
incontinence diagnosis (stress, urge, mixed), number of pads used per day, number of 
pregnancies, method of  delivery (vaginal, C-section, both), presence of 
pelvic/abdominal/back  pain (yes/no),  presence of pelvic organ prolapse (yes/no), history 
of pelvic surgery (yes/no), history of diabetes (yes/no), cardiovascular disease (yes/no) 
hypertension (yes/no) and stroke (yes/no), COPD/asthma (yes/no), bladder/kidney 
infections (yes/no) , neurologic disorders (yes/no), and specific medications.  
Classifications of medications that are of primary interest include diuretics, central 
nervous system depressants, hormones, anticholinergics, and antihistamines.  Other 
medications that can affect bladder function will also be noted. 
 Urinary incontinence and pregnancy, process of childbirth and method of delivery 
have been strongly associated and documented in the literature (Foldspang, Mommsen, & 
Djurhuus, 1999; Rortveit, Hannestad, Daoltweit, & Hunskaar, 2001; Wesnes, Hunskaar, 
& Rortveit, 2009).  Research suggests that prolonged stages of labor and delivery have 
more of an impact on post-natal urinary incontinence than method of delivery; however 
data for post-natal urinary incontinence after C-section are inconclusive. In this study the 
number of pregnancies and methods of delivery will be noted as vaginal, C-section, or 
both.   
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Muscles and ligaments cradle and support the pelvic floor structures of the 
bladder, urethra, vagina and uterus.  Excessive stress on these muscles and ligaments 
from overweight, birth trauma, prolonged heavy lifting, and chronic coughing cause 
weakness that can result in pelvic organ prolapse. Patients who have had a hysterectomy 
are also at risk for prolapse as the uterus acts as a support structure for the pelvic floor.  
When the uterus is removed, an important support is also removed so there is an 
association between pelvic organ prolapse and urinary incontinence (Luft, 2006; Serati et 
al., 2011; Smith, 2004).  
The literature suggests that urinary incontinence is prevalent among individuals 
with chronic medical illnesses such as cardiovascular disease and diabetes (Boyd et al., 
2011; Lee, Cigolle, & Blaum, 2009; Lifford, Curhan, Hu, Barbieri, & Grodstein, 2005; 
Phelan et al., 2009; Rosso et al., 2011).  Neurologic bladder control with successful urine 
storage and emptying is the result of coordination between the parasympathetic and 
sympathetic nervous systems.  Patients with neuropathology, whether congenital or 
acquired, are at risk for urinary incontinence.  Patients who have urinary tract infections 
can experience urinary incontinence when the irritated bladder causes urgency and 
frequency.  Illnesses, infection and neuropathic disorders will be noted and summed. 
Some medications like diuretics, central nervous system depressants, hormones, 
anticholinergics and antihistamines have shown the potential to impact bladder function 
and may result in urinary incontinence (Keister & Creason, 1989).  This researcher is 
interested in whether or not a patient takes medication (yes/no) from any of the selected 
drug classifications. However, the dosing regimens are not of interest in this study.  The 
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number of the classifications of medications (from 0 being none to the number they are 
using) that patients are taking will be summed for the medication variable.   
Health Behaviors.  Conservative therapies that help to manage urinary 
incontinence will be included as health behaviors; these include diet and fluid 
management, bowel management and Kegel exercises.  Use of conservative therapies 
will be reported as yes (1) or no (0).  The types of therapies the patients participate in will 
then be summed with scores ranging from 0 (none) to 3.  Data regarding the use of 
conservative therapies will be reported, before ExMI treatment and during ExMI 
treatment.  For patients who repeat ExMI treatment, use of conservative therapies post 
ExMI will also be noted.  
Physical Findings.  Several physical findings may be associated with urinary 
incontinence.  These include cystocele, rectocele, and uterine prolapse, vaginal/rectal 
tone and grip.  Cystocele and rectocele are herniations of the bladder and rectum in to the 
vagina. This occurs when there is weakening of the pelvic floor muscles. Uterine 
prolapse is the dropping of the uterus into the vagina which results when the ligaments 
that support the uterus are overstretched.  Vaginal and rectal tone and grip are indicators 
of pelvic floor muscle strength. These physical findings are discovered during the 
medical examination and are noted in the patients’ records on the Continence Center 
Intake Form.  Cystocele, rectocele, and uterine prolapse are described as no (0) or yes (1) 
and if yes, its station with respect to the introitus: slight (1), to introitus (2), beyond 
introitus (3).  Vaginal/rectal tone is described as normal (1) or abnormal (0) and grip is 
described as sustained (1) or not sustained (0).   
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Pressure and pain in the pelvis, lower abdomen and lower back are common 
complaints for patients with pelvic organ prolapse; (Lau, Weinstein, Wakamatsu, 
Macklin, & Pulliam, 2013; Reddy, Barber, Walters, Paraiso, & Jelovsek, 2011). The 
literature suggests that ExMI may have an ameliorating effect on pain.  Pain is assessed 
prior to beginning ExMI treatment and will be recorded as no (0) or yes (1).  
Clinical Outcomes 
 Urinary incontinence was measured by the dependent variable, number of pads 
used per day, as reported by the patient.  The number of pads used in a day was noted at 
the beginning and end of treatment and.  For patients who returned to repeat the protocol, 
the number of patients as well as how long (how many weeks) between treatment 
protocols was included in clinical outcomes.  The number of pads used in a day are 
compared from beginning to end of treatment and are markers that are frequently used to 
determine if a treatment for urinary incontinence has been successful.  There is very 
limited literature related to the effect of ExMI on pad usage or wetting episodes, but one 
multicenter study of ExMI for stress incontinence revealed that pad usage was reduced 
from 2.5 to 1.3 per day (p=0.001) and the number of wetting episodes was reduced from 
3.3 to 1.7 (p=0.001) per day (Galloway et al., 1999). 
Any reports of benefits unrelated to reduction in incontinence are also included in 
clinical outcomes.  The literature indicates that the application of pulsed electromagnetic 
fields has therapeutic benefits including pain relief, increased blood flow, and tissue 
healing.  For this reason, any patient-reported benefits unrelated to improvement in 
incontinence are included and described. 
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Procedure 
 Once institutional review board (IRB) approval was obtained from Georgia State 
University and the healthcare system where data was collected, a list of all patients who 
received ExMI treatment was provided through the offices of clinical research for the 
urology department and health information management.  Because electronic records 
were not available for these patients, archived records were reviewed. 
A data collection sheet (Appendix D) was created to hold all data abstracted from 
the medical records. Each record was assigned a study number that was used instead of 
patient names.  A key code sheet with information that could link the study number with 
the patient was stored separately from the data to protect privacy.  All study information 
is stored in a locked file cabinet owned by this researcher. Names or other facts that could 
identify the patients will not appear when the study is presented or when results are 
published.  
Design and Data Analysis 
 A descriptive, retrospective, secondary analysis of medical records was 
performed.  Frequencies and percentages were calculated for gender, diagnosis (stress, 
urge, mixed), health behaviors (dietary/fluid management, bowel management), 
medications (diuretics, central nervous system depressants, hormones, anticholinergics 
and antihistamines), physical findings (cystocele, rectocele, uterine prolapse, 
vaginal/rectal tone/grip), medical history (length of incontinence, pelvic surgery, 
cardiovascular disease, hypertension, diabetes, neurological disorders, stroke, 
COPD/asthma, bladder/kidney infections, pain (pelvic, abdominal, back), pregnancies, 
number and methods of delivery, number of patients who repeated the treatment protocol, 
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number of pads used per day before treatments and number of pads used per day after the 
treatments.  Means, standard deviations and ranges were calculated for age, weight and 
number of pregnancies.  T-tests were performed to examine the differences in 
improvement (reduction in pad usage) with respect to age, weight, gender, pain, pelvic 
surgery, number of deliveries, and daily pad usage at the beginning of treatment and at 
the end of treatment. Analyses of correlation were performed to examine the association 
between age, weight, number of pregnancies, number of deliveries and improvement 
(reduction in pad usage). 
 Summary 
 This chapter has described the purpose, objectives, design, sample, data collection 
and data analysis that were used in this study.   
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CHAPTER IV 
 
RESULTS 
 The results of a retrospective review of all patients who were treated for urinary 
incontinence with ExMI, a description of the sample and a discussion of the research 
objectives are presented in this chapter.  Research objectives were modified due to 
sample size limitations and available information that was documented in the archived 
records.   
 All medical records for patients who received ExMI from 2000 through 2012 
were examined.  Data was collected on a total of 43 patients.  Of those 43 patients, thirty-
five were treated for urinary incontinence.  Each of the 35 patients received the same 
treatment protocol of 15 Hz for 10 minutes, a two-minute rest period, and 40 Hz for 10 
minutes.  Each patient received two treatments a week for eight weeks.  Eight patients 
were excluded for various reasons ranging from receiving ExMI for a condition other 
than urinary incontinence to being lost to follow-up.  Those patients who were excluded 
will be discussed separately.   
Sample Characteristics 
The mean age of the patients in this study (n=35) was 63.4 years (SD=12.38).  
There were 26 (74%) females and nine (26%) males. Of the 26 females, 11 had stress 
incontinence, six had urge incontinence, and nine had mixed incontinence.  Of the nine 
males, five had stress, one had urge and three had mixed incontinence. Eight males were 
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treated post- prostatectomy and they had either stress or mixed incontinence.  The one 
male with urge incontinence had not undergone prostatectomy. See Table 1. 
 Weight was calculated separately for males and females. One female was an 
extreme outlier weighing 416 pounds; her weight was removed from this calculation to 
give a more accurate description of this sample. The mean weight for the nine males was 
177.6 (SD=26.33) pounds and the mean weight for the remaining 25 females was 140.9 
(SD=24.86) pounds. See Table 2.  
Table 1 
Type of Urinary Incontinence by Gender N=35 
Gender Stress Urge Mixed 
 
N 
 
Female 11 6 9 
 
26 
 
Male 5 1 3 9 
 
 
Table 2 
 
Weight by Gender *N=34 
 
Gender N Range M 
 
SD 
 
Female 25 112-222 140.9 
 
24.87 
 
Male 9 125-215 177.6 26.33 
 
*One female was an extreme outlier at 416 pounds and was removed from this 
calculation 
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Research Objective 1:  Examine the differences in selected demographics (age in years, 
gender, weight in pounds) and relationship among health behaviors (dietary/fluid 
management, bowel management), medications (diuretics, central nervous system [CNS] 
depressants, hormones, anticholinergics, antihistamines, others as appropriate to bladder 
function), physical findings (cystocele, rectocele, uterine prolapsed, vaginal/rectal 
tone/grip), medical history (length of incontinence, pelvic surgery, cardiovascular 
disease, hypertension, diabetes, neurologic disorders, stroke, COPD/asthma, 
bladder/kidney infections, pelvic/abdominal/back pain, pregnancies, methods of delivery, 
and number of pads used per day prior to treatment), between patients with stress, urge, 
and mixed urinary incontinence. 
 All 35 patients were given instruction for a dietary/fluid management and bowel 
management program prior to beginning ExMI.  Only one patient admitted to not 
following the program while receiving treatment.  No statistical calculation was made for 
these variables since all patients were placed on this routine.  
Patients who were treated with ExMI completed an intake record at their initial 
visit to the medical center.  In this record patients disclosed medical history, previous 
surgeries and listed any medications that they were taking. Forty percent of all patients 
were on hormone therapy and approximately 49% of patients were taking 
anticholinergics and antihistamines.  Medications that could impact bladder function 
were recorded and are summarized in Table 3. 
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Table 3 
Patient Medications 
N=35 
Medications Frequency 
 
Percentage 
 
 
Diuretics 
 
5 
 
14.29 
 
Hormones 14 40.00 
Anticholinergics 7 20.00 
Antihistamines 10 28.57 
CNS Depressants 8 22.86 
 
 Part of the medical history included acute or chronic illnesses that could impact 
continence, pelvic surgeries, and pain were of interest. Fourteen women had 
hypertension, eight had cardiovascular disease and one woman was a diabetic. Of the 
men, two had hypertension, two had cardiovascular disease and one was a diabetic. 
Neurologic disorders included one patient with Parkinson’s, one patient with cerebral 
palsy and hemiplegia, and three patients who had experienced neurological deficits that 
required spinal fusion surgeries. Patients who had pelvic surgery included eight men who 
had prostatectomies, eleven women who had hysterectomies, one woman who had 
bladder suspension and one woman who documented “many pelvic surgeries”. Of the 
eight patients who experienced pain, five complained of pelvic pain and three complained 
of back pain.  Table 4 summarizes medical history with regard to acute and chronic 
illness, pelvic surgery and pain. 
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Table 4  
Medical History: Acute and Chronic Illness, Pelvic Surgeries & Pain 
N=35 
Condition Frequency 
 
Percentage 
 
 
CVD 
 
10 
 
28.57 
 
HTN 16 45.71 
Diabetes 2 5.71 
Neurologic Disorder 5 14.29 
Bladder/Kidney Infection 4 11.43 
Pain 8 22.86 
Pelvic Surgery 21 60.00 
 
Medical history also included pregnancies and methods of delivery. Most women 
had 2 or 3 pregnancies (57%) and delivered vaginally (85%).  Two women had both 
vaginal and C-section deliveries (10%). Pregnancies and methods of delivery are 
presented in Table 5. 
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Table 5 
Number of Pregnancies and Methods of Delivery 
N=26 
Number of Pregnancies Frequency 
 
Percent 
 
 
0 
 
5 
 
19.23 
 
1 2 7.69 
2 10 38.46 
3 5 19.23 
4 1 3.85 
5 2 7.69 
6 1 3.85 
 
Methods of Delivery   
 
Vaginal 
 
17 
 
85.00 
 
C-Section 1 5.00 
Both 2 10.00 
 
  Most patients had experienced urinary incontinence between 1 to 5 years (69%). 
When separated by gender, five of nine men (56%) were incontinent for two years or 
less, whereas only eight of 26 women (31%) were incontinent for two years or less.  
Eighteen women (69%) were incontinent for three or more years.  Length of time of 
incontinence is presented in Table 6. 
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Table 6 
Length of Time of Incontinence 
N=35 
Incontinence Frequency 
 
Percent 
 
 
< 1 year 
 
10 
 
28.57 
 
1-2 years 16 45.71 
3-5 years 2 5.71 
6-10 years 5 14.29 
> 10 years 4 11.43 
 
Physical examination findings included 12 patients with cystocele (44.44%), and 
11 with rectocele (42.31%).  Uterine prolapse was not documented for any of the 
patients.  Vaginal tone was abnormal in 16 patients (61.54%) with grip not sustained in 
23 patients (88.46%).  Rectal tone was abnormal in 10 female and 7 male patients 
(48.57%) with rectal grip not sustained in 19 female and 8 male patients (77.14%).   
Research Objective 2: Explore the relationship of selected demographics (age in years, 
gender, weight in pounds), health behaviors (dietary/fluid management, bowel 
management), medications (diuretics, central nervous system [CNS] depressants, 
hormones, anticholinergics, antihistamines, others as appropriate to bladder function), 
physical findings (cystocele, rectocele, uterine prolapse, vaginal/rectal tone/grip), medical 
history (length of incontinence, pelvic surgery, cardiovascular disease, hypertension, 
diabetes, neurologic disorders, stroke, COPD/asthma, bladder/kidney infections, 
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pelvic/abdominal/back pain, pregnancies, methods of delivery, and number of pads used 
per day prior to treatment), and post-treatment pad usage following ExMI treatment for 
urinary incontinence. 
 Patients documented the number of pads they used daily at the beginning of 
treatment and again at the end of treatment.  Before treatment, 37% of patients used one 
to two pads daily, but 63% of patients used three to five pads daily.  After treatment, 31% 
of patients were no longer using pads, 54% had reduced daily pad usage to one or two 
and only 14% were using three or four pads daily.  Daily pad usage at the start of 
treatment and at the end of treatment is summarized in Table 7. 
Table 7 
Pad Usage 
Pad Usage Before 
Treatment Frequency Percentage 
 
Cumulative 
Percentage 
 
 
1 
 
4 
 
11.43 
 
11.43 
 
2 
 
9 
 
25.71 
 
37.14 
 
3 
 
13 
 
37.14 
 
74.29 
 
4 
 
7 
 
20.00 
 
94.29 
 
5 
 
2 
 
5.71 
 
100.00 
 
 
(Table 7 Continues) 
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(Table 7 Continued) 
Pad Usage After 
Treatment Frequency Percentage 
 
Cumulative 
Percentage 
 
 
0 
 
11 
 
31.43 
 
31.43 
 
1 
 
14 
 
40.00 
 
71.43 
 
2 
 
5 
 
14.29 
 
85.71 
 
3 
 
2 
 
5.71 
 
91.43 
 
4 
 
3 
 
8.57 
 
100.00 
 
 
Patient outcome was measured by comparing the pad usage before treatment and 
at the end of treatment (16 weeks). A paired t-test was performed to examine the 
difference between daily pad usage in the beginning and at the end of treatment. Results 
in this study were significant (t(34)=10.23, p<.0001) with the average number of pads 
used daily being reduced to 1.63 + 0.94.   All but six patients saw improvement in urinary 
incontinence with the reduction of daily pad use (83%).  No patients experienced an 
increase in urinary incontinence or an increase in pad usage.  The improvement in the 
number of pads per patient is shown in Table 8. 
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Table 8 
Improvement by Number of Pads 
 
Number of Pads Patients 
 
Percent 
 
 
0 
 
10 
 
28.57 
 
1 16 45.71 
2 2 5.71 
3 5 14.29 
 
 To examine the difference in age and weight between those who had 
improvement (reduction in pad usage) and those who did not, an independent t-test was 
performed (Table 9). There was no evidence that the average age for those who improved 
was any different than for those who did not improve (t(33)=0.31, p=0.7606);  also no 
evidence that the average weight for those patients who improved was any different than 
for those who did not improve (t(33)=1.62, p=0.1154).  
Table 9 
Improvement with Regard to Age and Weight 
Variable Improvement N Mean SD 
Age No 
Yes 
6 
29 
64.83 
63.10 
8.93 
13.09 
Weight No 
Yes 
6 
29 
189.7 
151.7 
115.7 
29.02 
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With regard to gender (Table 10) using the independent t-test, no statistical 
difference in improvement (reduction in the number of pads used daily) was noted 
between males or females (t(33)= -0.67, p=0.5045) . 
Table 10 
Average Improvement (reduction in number of pads) for Males and Females 
Gender N Mean 
 
SD 
 
Male 9 1.44 
 
1.01 
 
Female 26 1.69 
 
0.93 
 
 
 There was no significant difference in improvement for patients who experienced 
pain (M=1.25, SD=1.17) and those who did not experience pain (M=1.74, SD=0.86; 
t(33)=1.31, p=0.2000).  Patients who had undergone pelvic surgery (M=1.76, SD=0.10) 
and those patients who had not undergone pelvic surgery (M=1.43, SD=0.85; 
 t(33)=-1.03, p=0.312) did not differ in improvement. 
 When looking at frequencies for improvement by diagnosis, 16 patients (100%) 
with stress incontinence, 5 patients (71%) with urge incontinence, and 8 patients (67%) 
with mixed incontinence reported improvement (reduction in pad usage).  Because the 
sample was small, a Fisher’s Exact Test was performed. While patients with stress 
incontinence experienced overall greater reduction in pad usage than patients with urge or 
mixed incontinence, the results were not statistically significant (p=0.2328). 
 Frequencies for improvement by length of time of incontinence revealed that 29 
patients (83%) experienced improvement by reduction in pad usage by 1 to 3 pads a day.   
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Nineteen of these patients (54%) had been incontinent for three or more years.  Although 
clinically interesting, the overall improvement by length of time of incontinence was not 
statistically significant (p=0.8743).  
 Frequencies for improvement by patients who had previous pelvic surgery 
indicated that 29 patients (83%) experienced improvement by 1 to 3 pads a day.  
However, six patients who also had previous pelvic surgery had no reduction in pad 
usage. Overall these results were not significant (p=1.000) indicating that having pelvic 
surgery did not result in a significant reduction in pad usage. 
 Pearson product moment correlations were performed to assess the relationships 
between improvement and the variables of age, weight, number of pregnancies, and 
number of deliveries.  One patient’s weight was in excess of 400 pounds. This outlier’s 
data was removed from the analysis.  No correlations were found between improvement 
and age (r=0.038, n=35, p=0.827), improvement and weight (r=-0.0188, n=34, p=0.288), 
improvement and number of pregnancies (r=0.203, n=26, p=0.320), or improvement and 
number of deliveries (r=0.01, n=23, p=0.9666).  
Research Objective 3:  Describe the patients who returned for additional ExMI 
treatments. 
Four patients repeated the treatment protocol.  These returning patients were all 
females with a mean age of 64 (SD=12.19) and mean weight of 133 pounds (SD=13.14).  
Two of the women had mixed incontinence, one had stress and one had urge 
incontinence.  All four of the women had been pregnant (a total of 15 pregnancies) and 
three had delivered vaginally; only one had delivered by Cesarean. All were instructed to 
follow the same fluid/dietary management and bowel management program that they had 
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used during the first treatment protocol.  It is not known if these patients had continued 
the fluid and bowel program after they completed the first treatment protocol to the time 
of their return or if they had stopped using those conservative techniques. The length of 
time between protocols varied significantly. One patient returned after nine months, one 
returned after two years, one after three years and one after six years.  Two of the patients 
were using two pads daily when they began the second protocol and after the eight weeks 
treatment had reduced to zero pads.  The other two patients began with three pads a day 
and reduced to one pad a day.  All returnees had good results and none of the returnees 
came back for a third treatment protocol. 
Eight patients were excluded for various reasons. Of the eight patients who were 
omitted, five were males and three were females. Of the eight patients who were 
excluded from the study, one was a female who had severe paravaginal defects and who, 
after four weeks of treatment, discontinued care to have surgery.  One was a female who 
had a rectovaginal fistula as a result of birth trauma. She received eight weeks of 
treatment, but did not have improvement in fecal incontinence and had surgical repair of 
the fistula.  The other two patients attended for two weeks receiving a total of four 
treatments, but failed to keep any additional appointments and were lost to follow-up.  
Research Objective 4:  Describe any benefits received unrelated to reduction of urinary 
incontinence 
Four patients benefited from ExMI unrelated to urinary incontinence. All four of 
the patients were males with a mean age of 58.5 (SD=8.39) and mean weight of 180.75 
(SD=26.03). One patient had undergone colon cancer surgery and radiation which 
resulted in rectal and pelvic floor spasms with occasional fecal leakage.  This patient 
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received a treatment prescription of 50 Hz for 10 minutes followed by a two minute rest 
period and an additional 50 Hz for 10 minutes twice a week for eight weeks.  With a high 
frequency setting at 50 Hz the muscles of the pelvic floor are unable to contract and 
relax, and instead there is a tetanic contraction.  This setting is most commonly used in 
electrical stimulation devices for alleviation of pain. At the completion of 16 weeks, this 
patient reported that the pain had become less constant and more manageable. 
The second patient who had pain and fecal incontinence had undergone 
cystoprostatectomy and creation of an orthotopic neobladder.  He presented with fecal 
incontinence, pelvic pain, erectile dysfunction and urinary incontinence from the 
orthotopic neobladder for which he wore condom catheters.   This patient also received a 
prescription of 50 Hz for 10 minutes followed by a two minute rest period and an 
additional 50 Hz for 10 minutes twice a week for eight weeks.  By the end of his 
treatments this patient reported “significant improvement” in his pain as well as in the 
fecal incontinence.  There was no appreciable improvement in the urinary leakage, 
however, and the patient continued to wear condom catheters. 
The third patient presented with scrotal and rectal pain, and irritative symptoms of 
urinary frequency and nocturia, but no urinary incontinence. This patient’s medical 
history was significant for cervical spine defects with radiculopathy and cervical 
spondylosis, left hip neuropathy and sleep apnea.  He had been managing his pain with 
gabapentin and amitriptyline.  His prescription was the standard 15 Hz for 10 minutes, a 
two minute rest period, and 40 Hz for 10 minutes.  This patient completed the eight week 
regimen of treatments and reported that he had received relief from pain and urinary 
frequency within the first few visits. 
63 
 
 
 
Diagnosed with interstitial cystitis (IC), the final patient received treatment for 
pain, urgency, frequency and nocturia. There were no surgeries documented for this 
patient and his only history beside IC was atrial fibrillation and hypertension.  His 
medications included Atenolol and Elmiron which he had taken for IC for two years.  
After the standard prescription for eight weeks this patient reported pain, urgency, 
frequency and nocturia had improved. 
Summary 
 The characteristics of the study sample and the results of data analysis related to 
the research objectives were presented in this chapter.  While there was a total of 43 
patients who received this treatment, 35 patients were treated solely for urinary 
incontinence.  Most of the patients were women (n=26, 74%) and most patients had stress 
urinary incontinence (n=16, 46%) or mixed urinary incontinence (n=12, 34%). Patient 
outcome was measured by comparing the pad usage before treatment and at the end of 
treatment (16 weeks).  The average number of pads used daily was significantly reduced 
from 2.82 + 1.15 to 1.6 3 + 0.94 (p<.0001).  Testing to evaluate comparisons and 
correlations for other variables within the research objectives did not demonstrate 
statistical significance. 
Excluded from the central study, two patients with pelvic pain and fecal 
incontinence and two patients with pelvic pain alone received treatment for their 
respective conditions with ExMI. All four patients reported improvement in their 
symptoms.  Although rating scales are commonly used in reporting pain levels, only 
subjective reports of symptom relief were available for these patients.  When considering 
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quality of life, even a small improvement in pain or reduction in episodes of fecal 
incontinence could be considered clinically significant by that patient. 
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CHAPTER V 
 
DISCUSSION 
 In this study, clinical outcomes for patients who received Extracorporeal 
Magnetic Innervation therapy for urinary incontinence were examined.  This chapter 
presents a discussion of study findings as well as limitations and implications for nursing 
practice. 
  The goal of ExMI treatment is to strengthen the pelvic floor muscles to the 
extent that when the patient laughs, coughs or sneezes, they can engage those muscles 
and prevent urine leakage.  The clinical outcomes of a retrospective study of patients 
receiving ExMI treatment are presented below. 
Sample 
 A total of 43 patients received ExMI from 2000 through 2012.  Of those 43 
patients, 35 were treated for urinary incontinence and were included in this study.  The 
eight remaining patients were treated for conditions other than urinary incontinence or 
were lost to follow-up; those cases are discussed separately.   
Of the 35 patients, 26 were females and nine were males. That women were 
disproportionately represented in the sample is supported by the literature that maintains 
more women than men experience urinary incontinence (Katz, 2009; Moore & Gray, 
2004; Riss & Kargl, 2011).  This is an expected finding since previous studies that 
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explored ExMI for urinary incontinence also recruited more women than men 
participants unless the study was specific to male incontinence post-prostatectomy.   
Most of the patients would be considered to fall within the older adult category.  
Although the age range of the sample was 21 to 91 years, the mean age was 63.4 years 
(median=64 years). This is an expected finding and is supported by the literature (Bakar, 
Ozdemir, Ozengin, & Duran, 2010; Moore & Gray, 2004).  In aging adults, normal 
physiological changes such as loss of tissue elasticity or general weakening of pelvic tone 
can result in urinary incontinence. Prostate enlargement is a common cause of voiding 
problems in older men and atrophic changes in the vagina and urethra as a result of 
decreased estrogen levels is a common problem in older women. 
 Prior to, throughout, and following ExMI treatment, all patients were instructed to 
follow a fluid/dietary management plan instructing them to avoid bladder irritants such as 
caffeine, highly acidic foods and juices, carbonated drinks and artificial sweeteners. 
Patients were also instructed to drink adequate fluids (six to eight 8-ounces) daily. While 
some patients might overindulge in liquids, most patients who have experienced 
incontinent episodes will reduce their daily fluid intake to prevent incontinent episodes.  
Concentrated urine alone can cause irritating symptoms which can increase urgency, 
frequency and leakage.  By avoiding bladder irritants the patient may be able to remove 
the stimulant that contributes to urinary frequency, urgency and leakage. In addition, all 
patients were instructed to begin a bowel program using a fiber supplement and, if 
necessary, a stool softener to effectively empty their bowel and keep it empty.  The bowel 
and bladder communicate through neural pathways that allow for normal function.  If the 
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bowel is sluggish and the patient becomes constipated, the bladder also receives the 
message, resulting in urinary dysfunction. Patients who present with urinary incontinence 
are often troubled with chronic constipation.  While this is not an indication of major 
neurologic disease, it demonstrates the neurologic link between bowel and bladder 
function.  Although compliance with this fluid/dietary/bowel management plan is 
important to the success of ExMI treatment, statistical testing was not performed on this 
variable since all patients were placed on these routines and reported adherence to the 
regimen. 
 Many of the patients in this study were on medications for various medical 
conditions which could have an effect on bladder function. Diuretics are known to 
increase urgency, frequency and urinary output. Commonly prescribed for patients who 
have cardiovascular problems or hypertension, five patients were taking diuretics. The 
CNS depressants, anticholinergics, and antihistamines can all cause urinary retention by 
either relaxing the bladder or increasing bladder outlet resistance.  Eight patients were 
taking CNS depressants, seven patients were taking anticholinergics, and 10 patients 
were taking antihistamines.  It was not documented as to whether the patients were taking 
these medications to help them manage their incontinence or if they were on the 
medications for some other reason. Fourteen patients were taking hormones.  Used to 
improve the condition of vaginal and urethral tissues, hormonal replacement, either oral 
or topical can be very helpful in the treatment of urinary incontinence. Most of the 
patients in this study were older women, so it was a reasonable finding that 40% of the 
patients were on hormone replacement.  There were no changes in medications 
documented from pre to post treatment. 
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 In reviewing past medical history among the patients in this study, it was not 
surprising to find that cardiovascular disease and hypertension were very prevalent since 
these conditions are prevalent among the general aging population.  The risk of 
cardiovascular disease increases for women past menopause due to the loss of estrogen.  
Indirectly, the medications for these conditions, such as diuretics, may be implicated in 
incontinence.  Previous pelvic surgery which included hysterectomy and prostatectomy 
were also prevalent among these patients.  For females, the removal of the uterus alters 
pelvic floor support and can predispose the patient to leakage of urine.  In men, the 
prostate gland offers some mechanical protection from incontinence. Prostatectomy 
removes that barrier. 
 Five of the eight patients in this study who complained of pain experienced pelvic 
pain. Pelvic pain is a common complaint, but the origin of the pain may not be obvious 
making assessment and treatment difficult. Pelvic floor laxity with subsequent prolapse 
of the bladder or rectum, damage to the pudendal nerve related to birth trauma (Hompes, 
Jones, Cunningham, & Lindsey, 2010) and pelvic floor spasm related to prolonged 
sitting, pelvic surgery or traumatic vaginal delivery (Swisher, Rich, & Weiss, 2012) have 
all been implicated.   
 Physical examination findings revealed that most women in the study had some 
degree of pelvic floor dysfunction which includes cystocele and rectocele.  Abnormal 
vaginal or rectal tone and non-sustained grip were common findings in the sample as 
well.  Although these conditions are implicated in urinary incontinence, the sample was 
too small to show a relationship between these variables and the outcome. Detailed 
physical examination findings were not documented for the final (post treatment) visit. 
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 Approximately 69% of all patients in this study had experienced urinary 
incontinence between one and five years and nearly 29% had been living with 
incontinence ranging from six to over ten years.  Based on the information that was 
available, this researcher could not determine if these patients had tried and failed in their 
efforts to resolve their urinary incontinence prior to coming to this center.  It is difficult 
to predict when someone will seek care for incontinence.  Lack of knowledge about the 
disorder and what can be done for it rank high among reasons that patients cite for 
delaying medical care. Patients may feel that incontinence is just a normal part of aging 
that must be tolerated or they may fear treatment or medication that might be prescribed 
for them and the side effects they may cause.  Because incontinence is not a life 
threatening disorder, patients tend to ignore the symptoms until they are no longer 
tolerable and negatively impact other aspects of their lives. Primary care providers or 
specialists who care for these patients and help them manage other medical problems 
usually do not ask their patients if they experience urinary incontinence.  Initiating the 
conversation about incontinence with their patients might be helpful in removing the 
stigma associated with it and encourage more patients to seek help earlier. 
 Pregnancy and childbirth subject the muscles and ligaments of the pelvic floor to 
stretch and overload.  The gravid uterus takes up space and adds pressure to the 
surrounding structures.  Pregnancy has been likened to “being in a constant state of 
increased weight bearing” (Smith, 2004, p. 132). When the delivery takes place, 
stretching and tearing of the pelvic floor tissues occur.  Episiotomies are performed to 
limit tearing, but cutting through the perineum and posterior vaginal wall to assist in 
delivery still traumatizes the pelvic floor.  According to the CDC, Cesarean births 
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reached an all-time high in the United States in 2009, but have leveled off since that time 
(Osterman & Martin, 2013).  Cesarean deliveries are performed for various, complex 
reasons that may be medically necessary or may be controversial and performed for 
convenience or to limit liability.  The patients who were included in this study were 
pregnant and delivered prior to the time period when Caesarian sections were on the rise. 
Most of the women in this study who were pregnant had either two or three pregnancies 
and the majority (85%) of all pregnancies ended in vaginal delivery.  While there is a 
train of thought that Cesarean delivery can help to protect the structure and stability of 
the pelvic floor, maintaining continence in later years, this has not been definitively 
validated in the literature.  Only one patient in this study had a single Cesarean delivery 
and two patients had both vaginal and Cesarean deliveries.  It is this researcher’s opinion 
that this finding reflects obstetrical practices at the time of their deliveries and does not 
suggest that women who have Cesarean births experience less incontinence than women 
who have vaginal births.  
 In looking at the diagnoses of stress, urge or mixed incontinence, most of the 
patients experienced either stress or mixed incontinence. Stress incontinence is urinary 
leakage resulting from an increase in intra-abdominal pressure as would occur when 
coughing, laughing or with increased activity like lifting or running.  Urge incontinence 
is the result of an overactive bladder that prompts a strong, sudden need to urinate. Urge 
incontinence is generally the result of neurological dysfunction or irritative symptoms. 
Mixed incontinence is a combination of both stress and urge.  In the general population, 
the prevalence of both stress and mixed incontinence is greater than the prevalence of 
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urge incontinence alone (Nitti, 2001) and the findings in this sample are consistent with 
Nitti’s research.  
While there are several ways to measure treatment efficacy, comparing daily pad 
counts before a treatment regimen and after a treatment regimen is frequently used as an 
outcome marker to define the effectiveness of that treatment and is the method used in 
this study. The results in this study were significant (p<.0001) with the average number 
of pads used daily being reduced to 1.63 + 0.94.  Improvement by reduction in daily pad 
usage is consistent with the literature on ExMI (Almeida, Bruschini, & Srougi, 2001; 
Bakar, Ozdemir, Ozengin, & Duran, 2010; Doganay, Kilic, & Yilmaz, 2009; Galloway et 
al., 1999; Hoscan et al., 2008; Lo et al., 2013; Terzoni, Montanari, Mora, Ricci, & 
Destrebecq, 2012; Unsal, Saglam, & Cimentepe, 2003; Yamanishi et al., 2000; 
Yokoyama et al., 2004). When looking at improvement and gender, there was no 
difference in improvement as measured in reduction of daily pads between males or 
females.  Theoretically, pelvic floor muscle exercises (PFME) strengthen the muscles to 
improve urethral sphincter closure whenever there is an increase in intra-abdominal 
pressure.  These exercises have long been prescribed for male patients post-prostatectomy 
to help them regain continence, however, most of the literature on the efficacy of PFME 
focuses on women and not men, and this knowledge may not apply to the complex issues 
of incontinence in men.  In this study it does appear that the male patients did respond to 
ExMI as well as the female patients, suggesting that ExMI is equally effective in the 
management of urinary incontinence in men and women.   
Age, weight, medical history, pelvic surgeries, pain, medications, length of  
incontinence, physical exam findings, pregnancies, deliveries and type of incontinence 
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were not significantly associated with the reduction of daily pad usage (outcome) in this 
study.  Pearson product moment correlation testing did not demonstrate any relationships 
between age, weight, number of pregnancies or number of deliveries.  Other studies 
exploring the efficacy of ExMI have had similar results with regard to influence of study 
variables on outcomes.  Almeida, Bruschini, & Srougi (2004) explored duration of 
incontinence, history of hysterectomy, duration of menopause, BMI, patient age and type 
of incontinence and found that these variables had no influence on outcome in spite of 
improvement in the reduction of pad usage and improved quality of life for participants in 
that study.  ExMI studies by Ismail et al. (2009) and Voorham-Van der Zalm, Pelger, 
Stiggelbout, Elzevier, and Nijeholt (2006) both cite no significance related to the study 
variables and outcomes in their respective studies.  A small sample size is the consistent 
feature of these ExMI studies and this must be considered as a possible reason why the 
variables do not appear to influence outcomes. 
In this study there were four patients who repeated the treatment protocol. All 
four participants received good results with the first protocol, but urinary symptoms 
returned with increased incontinent episodes and pad usage prompting them to return for 
an additional series of treatments.  With any exercise program, if the exercise stops, the 
muscle tone is eventually lost, and this appears to hold true with ExMI.  Researchers have 
noted that improvement in urinary incontinence peaks during the treatment period, lasts 
up to a year, but then degrades.  Doganay, Kilic, & Yilmaz (2009) noted how the 
majority of patients experienced good results for up to a year after treatment, but then 
returned to baseline within three years of completion.   
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  Patients tend to delay seeking medical care for urinary incontinence until it 
becomes a problem that negatively affects other aspects of their lives.  It is unclear from 
the data if the patients who returned came back for more treatment soon after symptoms 
returned or if they waited until the symptoms could no longer be ignored. Knowing this 
information could help providers educate their patients about the possibility of needing 
additional treatments. The literature has shown that symptoms return a year or more after 
treatment ends.  What was unique about those patients who did not return?  Did they have 
sustained symptom relief, or did they choose not to return because the location for 
treatment was inconvenient, the treatment was too costly, or some other issue prevented 
them from returning?  Would “booster” treatments at specific intervals help patients 
maintain continence? 
Of the eight patients who were excluded from the study, one was a female who 
had severe paravaginal defects and who after four weeks of treatment, discontinued care 
to have surgery.  One was a female who had a rectovaginal fistula as a result of birth 
trauma. She received eight weeks of treatment, but did not have improvement in fecal 
incontinence and had surgical repair of the fistula.  The other two patients attended for 
two weeks receiving a total of four treatments, but failed to keep any additional 
appointments and were lost to follow-up.  There were four patients who received benefit 
from ExMI unrelated to urinary incontinence. Two had pelvic pain and two had fecal 
incontinence and pelvic pain. All four patients reported improvement in their symptoms.  
Previous ExMI studies in which individuals were treated for pain (Lyskov et al., 2005; 
Pipitone & Scott, 2001; Weintraub & Cole, 2004; Shupak et al., 2006) and fecal 
incontinence (Thornton, Kennedy, & Lubowski, 2005) had shown promise for patients 
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with these conditions.  While these four patients were not included in the main study, 
their response to treatment in light of the literature suggests that ExMI could be 
considered as a viable treatment option for patients with pelvic pain and fecal 
incontinence. 
Study Limitations 
 The most compelling limitation of this study was the small sample size.  Although 
the outcome of improvement by reduction of pad usage was significant, the study did not 
yield any significant relationships between other selected variables and the outcome. This 
could be a result of the very small size of the sample.  Because this was a retrospective 
chart review, the small size was unfortunate, but unavoidable.  
 When performing a retrospective record review the researcher must accept the 
data that is available and design a study with questions and variables that would be 
appropriate to the existing data.  Because the data was retrieved from existing patient 
records, the details and notes found were not bound by strict guidelines that would be 
established when designing a scientific inquiry and may not have included variables that 
would be of interest to the researcher.  The latter was an issue in this retrospective study. 
While the findings may not have been statistically significant with regard to a 
number of variables and outcome, it is possible that the patients who received even 
modest improvement would consider their outcome to be clinically significant.  There 
was no way to explore the patients’ perceptions of treatment effectiveness.  
Implications for Nursing Practice 
 Providing conservative therapies for continence care have traditionally fallen 
within the realm of nursing.  Nurses can provide the education patients need about their 
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condition.   They can teach patients the conservative measures such as pelvic floor 
muscle exercises, fluid management and bowel management that can help them attain 
some relief and control over their symptoms, and they can work with the patient’s 
provider to manage care and provide treatments as prescribed. 
 With regard to ExMI, this therapy holds great promise for patients with different 
diagnoses and pelvic floor dysfunctions.  With the aging of our population, it is 
reasonable to expect to see more patients needing continence care who might not desire 
or meet the criteria for surgical intervention.  Patients today are savvy healthcare 
consumers and are open to alternative therapies that can offer improvement without 
serious side effects.  Patient safety is of prime importance and throughout the literature, 
the absence of adverse effects related to the use of ExMI is repeatedly discussed 
(Culligan, Blackwell, Murphy, Ziegler, & Heit, 2005; Hoscan et al., 2008; Yamanishi et 
al., 2000).   
 At the present time this therapy is readily available and used extensively in over 
80 countries across the globe. Nurses in Italy who care for incontinent patients have the 
autonomy to decide if ExMI is right for their patients and to independently provide this 
treatment (Terzoni, Montanari, Mora, Ricci, & Destrebecq, 2012).  ExMI is prescribed 
less often in the United States than it was when it was first introduced, but this has less to 
do with treatment efficacy and more to do with availability of the technology, the 
problem patients had with getting to and from clinics that had the chair, cost of treatments 
and reimbursement issues. The good news is that engineers are looking at a new design 
that could address some of those problems and could renew interest in using ExMI in the 
United States (personal communication with Dr. N. Galloway).  
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Summary 
 This study has explored the relationships between specific variables and clinical 
outcomes involving the use of ExMI in the treatment of urinary incontinence.  Results 
revealed that patients who received ExMI for incontinence experienced improvement as 
evidenced by reduction in daily pad usage that was statistically significant.  Age, weight, 
medical history, pelvic surgeries, pain, medications, length of incontinence, physical 
exam findings, pregnancies, deliveries and type of incontinence were not significant with 
regard to the outcome.  Charts on all patients who received ExMI from 2000 to 2012 
were reviewed. Eight patients who did not meet the criteria for inclusion in this study, 
however four of these patients did experience benefits from ExMI treatment for other 
clinical conditions than a reduction in urinary incontinence; these cases were also 
discussed.  
77 
 
 
 
REFERENCES 
Abrams, P. (2003). Describing bladder storage function: Overactive bladder syndrome 
and detrusor overactivity. Urology, 62 (supplement 5B), 28-37.  doi: 
10.1016/j.urology2003.09.050 
Almeida, F.G., Bruschini, H., & Srough, M. (2004). Urodynamic and clinical evaluation 
of 91 female patients with urinary incontinence treated with perineal magnetic 
stimulation: 1-year follow-up. The Journal of Urology 171(4), 1571-1575.  doi: 
10.1097/01.ju.0000117791.72151.f8 
Athwal, B.S., Berkley, K.J., Hussain, I., Brennan, A., Craggs, M.,…Fowler, C.J. (2001). 
Brain responses to changes in bladder volume and urge to void in healthy men. 
Brain, 124 (2), 369-377. doi: 10.1093/brain/124.2.369 
Bakar, Y., Ozdemir, O., Ozengi, N., & Duran, B. (2011). The use of extracorporeal 
magnetic innervations for the treatment of stress urinary incontinence in older 
women: A pilot study. Archives of Gynecology and Obstetrics, 284(5), 1163-
1168. doi: 10.1007/s00404-010-1814-5 
Barroso, J.C.V., Ramos, J.G.L., Martins-Costa, S., Sanches, P.R.S., & Muller, A.F. 
(2005). Voiding function and dysfunction, bladder physiology and pharmacology, 
and female urology. The Journal of Urology, 174(3), 1007-1012.  doi: 
10.1097/01.ju.0000173945.31485.a6 
Baeken, C., DeRaedt, R., VanHove, C., Clerinx, P., DeMey, J., & Bossuyt, A. (2009).  
HF-rTMS treatment in medication-resistant melancholic depression: Results from   
18FDG-PET brain imaging. CNS Spectrums, 14(8), 439-448.  doi: 
10.1016/j.pnpbp.2010.03.021 
78 
 
 
 
Baessler, K., & Schuessler, B. (2003). Childbirth-induced trauma to the urethral 
continence mechanism: Review and recommendations. Urology, 62(s4A), 39-44.  
doi: 10.1016/j.urology.2003.08.001 
Bannister, J.J., Lawrence, W.T., Smith, A., Thomas, D.G., & Read, N.W. (1988).  
Urological abnormalities in young women with severe constipation.  Gut, 29,  
17-20. Retrieved from Gut.BMJ.org 
Blok, B.F.M., Sturms, L.M. & Holstege, G. (1998). Brain activation during micturition in 
women. Brain, 121(11), 2033-2042.   doi: 10.1093/brain/121.11.2033 
Bottomley, J.M. (2000). Complementary nutrition in treating urinary incontinence.  
Topics in Geriatric Rehabilitation, 16(1), 61-77. 
Boyd, C.M., Leff, B., Wolff, J.L., Yu, Q., Zhou, J., Rand, C., & Weiss, C.O. (2011).  
Informing clinical practice guideline development and implementation:  
Prevalence of coexisting conditions among adults with coronary heart disease.  
Journal of the American Geriatrics Society, 59(5). 797-805. doi: 10.1111/j.1532-
5415.2011.03391.x 
Bradshaw, H.D., Barker, A.T., Radley, S.C., & Chapple, C.R. (2003). The acute effect of 
magnetic stimulation of the pelvic floor on involuntary detrusor activity during 
Natural filling and overactive bladder symptoms. British Journal of Urology 
International, 91(9), 810-813. doi: 10.1046/j.1464-410X.2003.04235.x 
Brady, R., & Lamb, V. (2008). Assessment, intervention, and prevention of falls in elders 
with developmental disabilities. Topics in Geriatric Rehabilitation, 24(1), 54-63.  
  
79 
 
 
 
Brocklehurst, J.C. (1993). Urinary incontinence in the community—analysis of a MORI 
poll. British Journal of Medicine, 306 (6881), 832-834.   
doi: 10.1136/bmj.306.6881.832 
Brown, W.J., & Miller, Y.D. (2001). Too wet to exercise? Leaking urine as a barrier to 
physical activity in women. Journal of Science and Medicine in Sport, 4(4), 373-
378. doi: 10:1016/s1440-2440(01)80046-3 
Bump, R.C., & McClish, D.K. (1992). Cigarette smoking and urinary incontinence in 
women.  American Journal of Obstetrics and Gynecology, 167(5), 1213-1218.  
Abstract retrieved from http://www.ajog.org  
Bycroft, J.A., Craggs, M.D., Sheriff, M., Knight, S. & Shah, P.J.R. (2004). Does 
magnetic stimulation of sacral nerve roots cause contraction or suppression of the 
bladder? Neurourology and Urodynamics, 23(3), 241-245.   
doi 10.1002/nau.20009 
Byles, J., Millar, C.J., Sibbritt, D.W., & Chiarelli, P. (2009). Living with urinary 
incontinence: A longitudinal study of older women. Age and Ageing, 38(3), 333-
338. doi: 10.1093.ageing/afp013 
Chandi, D.D., Groenendijk, P.M., & Venema, P.L. (2004). Functional extracorporeal 
magnetic stimulation as a treatment for female urinary incontinence: ‘The chair’.  
British Journal of Urology International, 93(4), 539-542.  doi: 10.1111/j.1464-
410X.2004.04659.x 
Chapple, C., & Christmas, T. (1992).  Urodynamics Made Easy (chap. 2, p. 50).  
Edinburgh:  Churchill-Livingstone. 
  
80 
 
 
 
Choe, J.H., Choo, M-S., & Lee, K-S. (2007). Symptom change in women with overactive 
bladder after extracorporeal magnetic stimulation: A prospective trial.  
International Urogynecology Journal, 18(8), 875-880.  doi: 10.1007/s00192-006-
0261-0 
Chu, F.M., & Dmochowski, R. (2006). Pathophysiology of overactive bladder.  The 
American Journal of Medicine, 119 (3A), 3S-8S.  doi: 
10.1016/j.amjmed.2005.12.010 
Craven, R.F., & Hirnle, C.J. (2003). Fundamentals of nursing: Human health and 
function (4th ed.). Philadelphia: Lippincott, Williams, & Wilkins. 
de Groat, W. C. (1997). A neurologic basis for the overactive bladder.  Urology, 50 
(Suppl.6A), 36-52. 
Doganay, M., Kilic, S., & Yilmaz, N. (2010). Long term effects of extracorporeal 
Magnetic innervations in the treatment of women with urinary incontinence:  
Results of 3-year follow-up. Archives of Gynecology and Obstetrics, 282(1),  
49-53. doi: 10.1997/s00404-009-1243-5  
Doikno, A.C., Burgio, K., Fultz, N. H., Kinchen, K.S., Obenchain, R., & Bump, R.C. 
(2003). Prevalence and outcomes of continence surgery in community dwelling 
women. The Journal of Urology, 170(2), part 1, 507-511. 
doi:10.1097/01.ju.0000070404.24755.35 
Fitzgerald, P., Hoy, K., Daskalakis, Z., & Kulkarni, J. (2009).  A randomized trial of the 
anti-depressant effects of low- and high-frequency transcranial magnetic 
stimulation in treatment-resistant depression. Depression and Anxiety, 26, 229-
234. doi: 10.1002/da.20454 
81 
 
 
 
Foldspang, A., Mommsen, S., & Djurhuus, J.C. (1999). Prevalent urinary incontinence as 
a correlate of pregnancy, vaginal childbirth, and obstetric techniques.  American 
Journal of Public Health, 89(2), 209-212. doi: 10.2105/AJPH.89.2.209 
Fujishiro, T., Enomoto, H., Ugawa, Y., Takahashi, S., Ueno, S., & Kitamura, T. (2000). 
Magnetic stimulation of the sacral roots for the treatment of stress incontinence:  
An investigational study and placebo controlled trial. The Journal of Urology, 
164(4), 1277-1279. Retrieved from http://www.jurology.com/ 
Fultz, N.H. & Herzof, A.R. (2001). Self-reported social and emotional impact of 
urinaryincontinence. Journal of the American Geriatrics Society, 49(7), 892-899.  
doi: 10.1046/j.1532-5415.2001.49179.x 
Galloway, N., El-Galley, R., Sand, P., Appell, R., Russell, H., & Carlan, S. (1999). 
Extracorporeal magnetic innervation therapy for stress urinary incontinence.  
Urology, 53(6), 1108-1111. 
Garland, D., Adkins, R., Matsuno, N., & Stewart, C. (1999).  The effect of pulsed 
electromagnetic fields on osteoporosis at the knee in individuals with spinal cord 
injury.  The Journal of Spinal Cord Medicine, 22(4), 239-245. 
Goodwin, T. (2003).  Physiological and molecular genetic effects of time-varying 
electromagnetic fields on human neuronal cells. Houston:  National Aeronautical 
and Space Administration. 
Gray, M., Bliss, D.Z., Doughty, D.B., Ermer-Seltun, J., Kennedy-Evans, K.L., & Palmer, 
M.H. (2007). Incontinence-associated dermatitis: A consensus. Journal of Wound 
Ostomy and Continence Nursing, 34(1), 45-54. doi: 10.1097/00152192-
200701000-00008 
82 
 
 
 
Hagglund, D., Walker-Engstrom, M-L., Larsson, G., & Leppert, J. (2004). Changes in 
urinary incontinence and quality of life after four years. Scandinavian Journal of 
Primary Health Care, 22(2), 112-117. doi:10.1080/02813430410005676 
Hagglund, D., & Wadensten, B. (2007). Fear of humiliation inhibits women’s care 
seeking behaviour for long-term urinary incontinence. Scandinavian Journal of 
the Caring Sciences, 21(3). 305-312. doi: 10.111/j.1471-6712.2007.00481.x 
Hasegawa, J., Kuzuya, M., & Iguchi, A. (2009). Urinary incontinence and behavioral 
symptoms are independent risk factors for recurrent and injurious falls, 
respectively, among residents in long-term care facilities. Archives of 
Gerontology and Geriatrics, 50(1), 77-81. doi: 10.1016/j.archger.2009.02.001 
Hollenbeck, B.K., Lipp, E.R., Hayward, R.A., Montie, J.E., Schottenfeld, D., & Wei, J.T. 
(2002). Concurrent assessment of obstructive/irritative urinary symptoms after 
radical prostatectomy. Urology, 59(3), 389-393. doi: 10.1016/s0090-
4295(01)01580-1 
Hoscan, M.B., Dilmen, C., Perk, H., Soyupek, S., Armagan, A.,… Ekinci, M. (2008). 
Extracorporeal magnetic innervations for the treatment of stress urinary 
incontinence: Results of two-year follow-up. Urologia Internationalis, 81(2), 
167-172. doi: 10.1159/000144055 
Huang, A.J., Brown, J.S., Kamaya, A.M., Creasman, J.M., Ragins, A.I.,…Thom, D.H. 
(2006). Quality of life impact and treatment of urinary incontinence in ethnically 
diverse older women.  Archives of Internal Medicine, 166(18), 2000-2006. doi: 
10.1001/archinte.166.18.2000 
  
83 
 
 
 
Huerta, P. & Volpe, B. (2009). Transcranial magnetic stimulation, synaptic plasticity and 
network oscillations. Journal of Neuroengineering and Rehabilitation, 6(7).  
doi: 10.1186/1743-0003-6-7. 
Ismail, S.I.M.F., Forward, G., Bastin, L., Wareham, K., Emery, S.J., & Lucas, M.  (2009). 
Electromagnetic stimulation of pelvic floor muscles for urodynamic stress 
incontinence of urine in women. Journal of Obstetrics and Gynecology, 29(1),  
35-39.  doi: 10.1080/01443610802484393. 
Katz, A. (2009). When worlds collide: Urinary incontinence and female sexuality. 
American Journal of Nursing, 109(3), 59-63. 
doi:10.1097/01.naj.0000346934.20864.79 
Keister, K.J., & Creason, N.S. (1989). Medications of elderly institutionalized incontinent 
females.  Journal of Advanced Nursing, 14(11), 980-985. 
Kenkre, J., Hobbs, F., Carter, Y., Holder, R., & Holmes, E. (1996).  A randomized 
controlled trial of electromagnetic therapy in the primary care management of 
venous leg ulceration.  Family Practice, 13, 236-241.  
doi: 10.1093/fampra/13.3.236 
Kerr, L.A. (2005). Bulking agents in the treatment of stress urinary incontinence:  
History, outcomes, patient populations, and reimbursement profile.  Reviews in 
Urology, 7(S1), S3-S11. 
Keyock, K.L., & Newman, D.K. (2011). Understanding stress urinary incontinence.  The 
Nurse Practitioner, 36(10), 25-36. doi:10.1097/01.NPR.0000405281.55881.7a 
  
84 
 
 
 
Knuutinen, A., Kokkonen, N., Risteli, J., Vahakangas, K., Kallioinen, M.,…Oikarinen, 
A. (2002).  Smoking affects collagen synthesis and extracellular matrix turnover 
in human skin.  British Journal of Dermatology, 146(4), 588-594.  
doi: 10.1046/j.1365-2133.2022.04694x 
Kristensen, I., Eldoma, M., Williamson, T., Wood, S., Mainprize, T., & Ross, S. (2010). 
Complications of the tension-free vaginal tape procedure for stress  urinary 
incontinence. International Urogynecological Journal, 21(11), 1353-1357.  
doi: 10.1007/s00192-010-1210-5 
Kumar, V., Kumar, D., Kalaivani, K, Gangadharan, A., Raju, K.,…Puvanakrishnan, R. 
(2005).  Optimization of pulsed electromagnetic field therapy for management of 
arthritis in rats. Bioelectromagnetics, 26, 431-439. doi: 10.1002/bem.20100. 
Lagro-Janssen, T.A., Hilkens, C.J., Klaasen, R.I., & Teunissen, D. (2008). Greater 
emotional and social effect of urinary incontinence in men than women.  Journal 
of the American Geriatrics Society, 56(9), 1779-1781.  doi: 10.111/j.1532-
5415.2008.01842.x 
Lalande, A., Salve, N., Comte, A., Jaulent, M-C., Legrand, L.,…Brunotte, F. (2004).  
Left ventricular ejection fraction calculation from automatically selected and 
processed diastolic and systolic frames in short-axis cine-MRI. Journal of 
Cardiovascular Magnetic Resonance, 6(4), 817-827.  
doi: 10.1081/jcmr-200036143 
  
85 
 
 
 
Landefeld, C.S., Bowers, B.J., Feld, A.D., Hartmann, K.E., Hoffman, E.,…Trock, B.J. 
(2008). National Institutes of Health state-of-the-science conference statement: 
Prevention of fecal and urinary incontinence in adults. Annals of Internal 
Medicine, 148(6), 449-458. 
Langemo, D., Hanson, D., Hunter, S., Thompson, P. & Oh, I.E. (2011). Incontinence and 
incontinence-associated dermatitis. Advances in Skin and Wound Care, 24(3), 
126-140. doi: 10.1099/01.asw.0000395037.28398.6c 
Lau, T., Weinstein, M., Wakamatsu, M., Macklin, E.A. & Pulliam, S. (2013). Low back 
pain does not improve with surgical treatment of pelvic organ prolapse.  
International Urogynecology Journal, 24(1), 147-153.   
doi: 10.1007/s00192-012-1797-9 
Lee, P.G., Cigolle, C. & Blaum, C. (2009). The co-occurrence of chronic diseases and 
geriatric syndromes: The health and retirement study.  Journal of the American 
Geriatrics Society, 57(3), 511-516. doi: 10.1111/j.1532-5415.2008.02150.x 
Liebel, D.V., Friedman, B., Watson, N.M., Powers, B.A. (2009). Review of nursing 
home visiting interventions for community-dwelling older persons with existing 
disability. Medical Care Research and Review, 66(2), 119-146.   
doi: 10.1177/1077558708328815 
Lifford, K.L., Curhan, G.C., Hu, F.B., Barbieri, R.L. & Grodstein, F. (2005).  Type 2 
diabetes mellitus and risk of developing urinary incontinence.  Journal of the 
American Geriatrics Society, 53(11), 1851-1857.   
doi: 10.1111/j.1532-5415.2005.53565.x 
  
86 
 
 
 
Lo, T-S., Tseng, L-H., Lin, Y-H., Liang, C-C., Lu, C-Y., & Pue, L.B. (2013). Effect of 
electromagnetic energy stimulation on bothersome lower urinary tract symptoms 
and quality of life in female patients with stress urinary incontinence and 
overactive bladder. Journal of Obstetrics and Gynaecology Research, 39(11), 
1526-1532. doi: 10.111/jog.12090 
Luft, J. (2006). Pelvic organ prolapse: Current state of knowledge about this common 
condition. The Journal for Nurse Practitioners, 2(3), 170-177.  
doi:10.1016/j.nurpra.2006.01.010 
Lyskov, E., Kalezic, N., Markov, M., Mild, K., Thunberg, J., & Johansson, H. (2005). 
Low frequency therapeutic EMF differently influences experimental muscle pain 
in female and male subjects.  Bioelectromagnetics, 26, 299-304.   
doi: 10.1002/bem.20092 
MacKay, K., & Hemmett, L. (2001). Needs assessment of women with urinary 
incontinence in a district health authority. British Journal of General Practice, 
51(471), 801-804.  
MacKenzie, D., & Veninga, F. (2004).  Reversal of delayed union of anterior cervical 
fusion treated with pulsed electromagnetic field stimulation:  Case report.  
Southern Medical Journal, 97(5), 519-524. doi: 10.1097/00007611-200405000-
00021 
Macklis, R. (1993). Magnetic healing, quackery, and the debate about the health effects 
of electromagnetic fields. Annals of Internal Medicine, 118(5), 376-383. 
  
87 
 
 
 
Massari, L., Fini, M., Cadossi, R., Setti, S., & Traina, G. (2006).  Biophysical stimulation 
with pulsed electromagnetic fields in osteonecrosis of the femoral head.  The 
Journal of Bone and Joint Surgery, 88(3), 56-60.  doi: 10.2016/jbjs.f.00536 
Melville, J.L., Daton, W., Delaney, K., Newton, K. (2005). Urinary incontinence in 
women: A population based study. Archives of Internal Medicine, 165(5), 537-
542. doi: 10.1001/archinte.165.5.537 
Mert, T., Gunay, I., Gocmen, C., Kaya, M. & Polat, S. (2006).  Regenerative effects of 
pulsed magnetic field on injured peripheral nerves. Alternative Therapies, 12(5), 
42-49. 
Moore, K.L. & Dalley, A.F. (1999). Clinically oriented anatomy (4th ed., pp. 341-342). 
Philadelphia: Lippincott, Williams & Wilkins.  
Moore, K.N. & Gray, M. (2004). Urinary incontinence in men: Current status and future 
directions. Nursing Research, 53(6s), s36-s41. 
Moore, K.N., Griffiths, D., & Hughton, A. (1999). Urinary incontinence after radical 
prostatectomy: A randomized controlled trial comparing pelvic muscle exercises 
with or without electrical stimulation. British Journal of Urology International, 
83(1), 57-65. doi: 10.1046/j.1464-410x.1999.00894.x 
NAFC facts and statistics retrieved from http://www.nafc.org/media/media-kit/facts-
statistics/ 
Nahon, I., Dorey, G., Waddington, G.S., & Adams, R. (2009). Perceptions of 
embarrassment for men with and without urinary incontinence. Urologic Nursing, 
29(3), 164-170.  
  
88 
 
 
 
Nakagawa, H., Kaiho, Y., Namiki, S., Shigeto, I., Saito, S., & Arai, Y. (2010). Impact of 
sacral surface therapeutic electrical stimulation on early recovery of urinary 
Continence after radical retropubic prostatectomy: A pilot study. Advances in 
Urology, 2010, article ID 102751, 5 pages. doi: 10.1155/2010/102751 
Newman, D.K. (1998). Bladder control requires active management. Journal of Women's 
Health, 7(4), 425-426. doi: 10.1089/jwh.1998.7.425 
Nitti, V.W. (2001). The prevalence of urinary incontinence. Reviews in Urology, 3 
(suppl.1). s2-s8. Retrieved from 
www.ncbi.nlm.nih.gov/pmc/articles/PMC14760701 
O’Connell, B., Baker, L., & Munro, I. (2007). The nature and impact of incontinence in 
men who have undergone prostate surgery and implications for nursing practice.  
Contemporary Nurse, 24(1), 65-78. doi: 10.5172/conu.2007.24.1.65 
Palmer, M.H., Fogarty, L.A., Somerfield, M.R., & Powel, L.L. (2003). Incontinence after 
prostatectomy: Coping with incontinence after prostate cancer surgery. Oncology 
Nursing Forum, 30(2), 229-238. doi: 10.1188/03.ONF 
Palmieri, K., Mannikarottu, A.S., Chichester, P., Kogan, B., Leggett,R.E.,…Levin, R.M. 
(2007). The effects of cyclical oestrogen on bladder and urethral structure and 
function. British Journal of Urology International, 99(1), 171-176.  
doi: 10.1111/j.1464-410X.2007.06532.x 
Phelan, S., Kanaya, A.M., Subak, L.L., Hogan, P.E., Espeland, M.A., Wing, 
R.R.,…Brown, J.S. (2009). Prevalence and risk factors for urinary incontinence in 
overweight and obese diabetic women. Diabetes Care, 32(8), 1391-1397.   
doi: 10.2337/dc09-0516 
89 
 
 
 
Philpott, W., & Kalita, D. (2000).  Magnet Therapy. (chap. 1, p. 23).Tiburon, CA: 
Alternative Medicine, Inc. 
Pipitone, N., & Scott, D. (2001). Magnetic pulse treatment for knee osteoarthritis: A 
randomized, double-blind, placebo-controlled study. Current Medical Research & 
Opinion, 17(3), 190-196. 
Porth, C. (2011). Disorders of the bladder and lower urinary tract.  In Essentials of 
pathophysiology: Concepts of altered health states (pp. 662, 668). Philadelphia: 
Lippincott, Williams, & Wilkins. 
Ramundo, J.M., & Davis, K. E. (2002). State of the science: Pathology and Management 
of the patient with overactive bladder. Ostomy Wound Management, 48(12), 22-
27. 
Reddy, J., Barber, M.D., Walters, M.D., Paraiso, M.F.R., & Jelovsek, E. (2011). Lower 
abdominal and pelvic pain with advanced pelvic organ prolapse: A case-control 
study. American Journal of Obstetrics and Gynecology, 204(6), 537.e1-537.e5 
Riss, P., & Kargl, J. (2011). Quality of life and urinary incontinence in women.  
Maturitas, 68(2), 137-142. doi: 10.1016/jmaturitas.2010.11.006 
Robinson, D., & Cardozo, L.D. (2003). The role of estrogens in female lower urinary 
tract dysfunction.  Urology, 62 (Suppl. 4A), 45-51. doi: 10.1016/S0090-
4295(03)00676-9 
Roe, B., & Doll, H. (2000). Prevalence of urinary incontinence and its relationship with 
health status. Journal of Clinical Nursing, 9(5), 792-800. doi: 10.1046/j.1365-
2702.2000.00346.x 
  
90 
 
 
 
Rortveit, G., Hannestad, Y.S., Daltveit, A. K., & Hunskaar, S. (2001). Age-and type-
dependent effects of parity on urinary incontinence: The Norwegian EPINCONT 
study.  Obstetrics and Gynecology, 98(6), 1004-1010. doi:10.1016/s0029-
7844(01)01566-6 
Rosso, A.L., Eaton, C.B., Wallace, R., Gold, R., Curb, J.D., Stefanick, M.L.,…Michael, 
Y.L. (2011). Combined impact of geriatric syndromes and cardiometabolic 
diseases on measures of functional impairment.  Journal of Gerontology: 
Biological Sciences, 66A(3), 349-354.  doi: 10.1093/gerona/glq230 
Sakamoto, K., Sharma, S., & Wheeler, J.S. (2007). Long term subjective continence 
status and use of alternative treatments by women with stress urinary incontinence 
after collagen injection therapy. World Journal of Urology, 25(4), 431-433  
doi: 10.1007/s00345-007-0193-4 
Serati, M., Salvatore, S., Siesto, G., Cattoni, E., Bragga, A.,… Bolis, P. (2011).  Urinary 
symptoms and urodynamic findings in women with pelvic organ prolapse: Is there 
a correlation? Results of an artificial neural network analysis.  European Urology, 
60 (2011), 253-260. 
Shupak, N., McKay, J., Nielson, W., Rollman, G., Prato, F., & Thomas, A. (2006).  
Exposure to a specific pulsed low-frequency magnetic field:  A double-blind 
placebo-controlled study of effects on pain ratings in rheumatoid arthritis and 
fibromyalgia patients.  Pain Research Management, 11(2), 85-90.   
doi: 10.1016/j.neulet.2004.03.069 
  
91 
 
 
 
Smith, D. (2004). Female pelvic floor health: A developmental review. Journal of 
Wound, Ostomy and Continence Nursing, 31(3), 130-137. 
Smoger, S.H., Felice, T.L., & Kloecker, G.H. (2000). Urinary incontinence among male 
veterans receiving care in primary care clinics. Annals of Internal Medicine, 
132(7), 547-551.  
Soper, D.S. (2012). A-priori sample size calculator for multiple regression (online 
software), http://www.danielsoper.com/statcalc3 
St. John, W., Wallis, M., Griffiths, S., & McKenzie, S. (2010). Daily living management 
of urinary incontinence: A synthesis of the literature. Journal of Wound Ostomy 
and Continence Nursing, 37(1), 80-90. 
Stewart, W.F., Van Rooyen, J.B., Cundiff, G.W., Abrams, P., Herzog, A.R., & Corey, R., 
et al. (2003). Prevalence and burden of overactive bladder in the United States.  
World Journal of Urology, 20(6), 327-336. 
Strauch, B., Patel, M., Rosen, D., Mahadevia, S., Brindzei, N., & Pilla, A. (2006).  Pulsed 
magnetic field therapy increases tensile strength in a rat’s Achilles  tendon repair 
model.  The Journal of Hand Surgery, 31A(7), 1131-1135.   
doi: 10.1016/j.jhsa.2006.03.024 
Subak, L.L., Richter, H.E., & Hunskaar, S. (2009). Obesity and urinary incontinence:  
Epidemiology and clinical research update. The Journal of Urology, 182(7), S2-
S7. doi: 10.1016/j.juro.2009.08.071 
  
92 
 
 
 
Terzoni, S., Montanari, E., Mora, C., Ricci, C., & Destrebecq, A. (2013). Reducing urine 
leakage after radical retropubic prostatectomy: Pelvic floor exercises, magnetic 
innervation or no treatment? A quasi-experimental study. Rehabilitation Nursing, 
38(3), 153-160. doi: 10.1002/mj.72 
Thornton, M., Kennedy, M., & Lubowski, D. (2005).  Extracorporeal magnetic 
stimulation of the pelvic floor:  Impact on anorectal function and physiology.  A 
pilot study.  [Electronic version]. Diseases of the Colon & Rectum, 48, 1945-
1950. doi: 10.1007/s10350-005-0145-2 
Townsend, M.K., Curhan, G.C., Resnick, N.M., & Grodstein, F. (2010). The incidence of 
urinary incontinence across Asian, black, and white women in the United States.  
American Journal of Obstetrics and Gynecology, 202(4), 378.e1-378.e7.  
doi: 10.1016/j.ajog.2009.11.021 
Unsal, A., Saglam, R., Cimentepe, E. (2003). Extracorporeal magnetic stimulation for the 
Treatment of stress and urge incontinence in women. Scandinavian Journal of 
Urology and Nephrology, 37(5), 424-428. doi: 10.1080/00365590310021258 
Vanderhasselt, M-A, DeRaedt, R., Leyman, L., & Baeken, C. (2009).  Acute effects of 
repetitive transcranial magnetic stimulation on attentional control are related to 
antidepressant outcomes. [Electronic version]. Journal of Psychiatry 
Neuroscience, 34(2), 119-126. 
Voorham-Van Der Zalm, P., Pelger, R.C.M., Stiggelbout, A.M., Elzevier, H.W., & 
Lycklama, A., & Nijeholt, G.A.B. (2006). Effects of magnetic stimulation in the 
Treatment of pelvic floor dysfunction. British Journal of Urology International, 
97(5). 1035-1038. doi: 10.1111/j.1464-410X.2006.06131.x 
93 
 
 
 
Walker, J.S. (2004). Physics (2nd ed., p. 749-754). Upper Saddle New Jersey:  Pearson 
Prentice Hall. 
Wallner, L.P., Porten, S., Meenan, R.T., O’Keefe Rosetti, M.C., Calhoun, 
E.A.,…Clemens, J.Q. (2009). Prevalence and severity of undiagnosed urinary 
incontinence in women. The American Journal of Medicine, 122(11), 1037-1042. 
doi: 10.1016/j.amjmed.2009.05.016 
Wein, A.J. & Rackley, R.R. (2006). Overactive bladder: A better understanding of 
pathophysiology, diagnosis and management. The Journal of Urology, 175 (S5-
S10). doi:  10.1016/s0022-5347(05)00313-7 
Weintraub, M., & Cole, S. (2004).  Pulsed magnetic field therapy in refractory  
neuropathic pain secondary to peripheral neuropathy:  Electrodiagnostic 
parameters-pilot study.  Neurorehabilitation and Neural Repair, 18(1), 42-46. 
doi: 10.1177/0888439003261024 
Wesnes, S.L., Hunskaar, S., Bo, K., & Rortveit, G. (2009). The effect of urinary 
Incontinence status during pregnancy and delivery mode on incontinence 
postpartum. A cohort study. British Journal of Obstetrics and Gynaecology, 
116(5), 700-707. doi: 10.1111/j.1471-0528.2008.02107.x 
Wong, M.Y., Harmanli, O.H., Agar, M., Dandolu, V., & Grody, M. H. (2003).  Collagen 
content of nonsupport tissue in pelvic organ prolapsed and stress  Urinary 
incontinence. American Journal of Obstetrics and Gynecology, 189(6), 1599-
1600. doi: 10.1016/j.ajog.2003.09.043 
94 
 
 
 
Yamaguchi, S., Ogiue-Ikeda, M., Sekino, M., & Ueno, S. (2006).  Effects of pulsed 
magnetic stimulation on tumor development and immune functions in mice.  
Bioelectromagnetics, 24, 64-72. doi: 10.1002/bem.20177 
Yamanishi, T., Kamai, T & Yoshida, K-I. (2008). Neuromodulation for the treatment of 
urinary incontinence. International Journal of Urology, 15(8), 665-672.   
doi: 10.1111/j.1442-2042.2008.02080.x 
Yamanishi, T., Yasuda, K., Suda, S., & Ishikawa, N. (1999). Effect of functional 
continuous magnetic stimulation on urethral closure in healthy volunteers.  
Urology 54(4), 652-655. doi: 10.1016/s0090-4295(99)00194-6 
Yeung, C.K., Sihoe, J.D.Y., Sit, F.K.Y., Bower, W., Sreedhar, B., & Lau, J. (2004).  
Characteristics of primary nocturnal enuresis in adults: An epidemiological study. 
British Journal of Urology International, 93(9), 341-345.  doi: 10.1111/j.1464-
410x.2003.04612.x 
Yokoyama, T., Fujita, O., Nishiguchi, J., Nozaki, K., Nose, H.,…Kumon, H. (2004).  
Extracorporeal magnetic innervation treatment for urinary incontinence.  
International Journal of Urology, 11, 602-606.  doi: 10.1111/j.1442-
2042.2004.00857.x 
Yokoyama, T., Inoue, M., Fujita, O., Nozaki, K., Nose, H., & Kumon, H. (2005).  
Preliminary results of the effect of extracorporeal magnetic stimulation on urinary 
incontinence after radical prostatectomy:  A pilot study.  [Electronic version] 
Urologia Internationalis, 74(3), 224-228. doi: 10.1159/000083553 
  
95 
 
 
 
Yokoyama, T., Nishiguchi, J., Watanabe, T., Nose, H., Nozaki, K.,…Kumon, H. (2004). 
Comparative study of effects of extracorporeal magnetic innervation versus 
electrical stimulation for urinary incontinence after radical prostatectomy. 
Urology, 63(2), 264-267.  doi: 10.1016/j.urology.2003.09.024 
  
96 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendices
97 
 
 
 
Appendix A 
Letter from Emory IRB  
98 
 
 
 
Appendix B 
Letter from Dr. Niall Galloway 
99 
 
 
 
Appendix C 
Emory IRB Determination 
  
100 
 
 
 
Appendix D 
                                                     Data Collection Sheet 
 
Subject ID number      _____  _____  _____ 
 
Demographics 
Age (in years)      _____ 
Gender        _____ 
1. Male 
2. Female 
 
Weight (in pounds)      _____ 
 
Race/Ethnicity 
1. African American 
2. Asian/Pacific 
3. Caucasian 
4. Hispanic 
5. Native American 
 
Medical History 
 
Length of time of incontinence    _____ 
1. < 1   year  How many months? _____ 
2. 1-2   years 
3. 3-5   years 
4. 6-10 years  
5. > 10 years 
 
Diagnosis       _____ 
1. Stress Incontinence 
2. Urge Incontinence 
3. Mixed Incontinence 
 
Number of Pregnancies     _____ 
 
Methods of Delivery      _____ 
1. Vaginal 
2. C-Section 
3. Both 
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Number of Deliveries 
1. Vaginal      _____ 
2. C-Section      _____ 
3. Both       _____ 
 
Pain  
No (0) 
Yes (1)      _____ 
Location      _____ 
1. Pelvic 
2. Abdominal    Scale  0-10      _____ 
3. Back  
 
Disorders    
_____Cardiovascular 
_____Hypertension 
_____Diabetes 
_____Neurologic 
_____Stroke 
_____COPD/asthma 
_____Bladder/kidney infections 
 
Pelvic Surgery      _____ 
1. Yes 
Type of surgery: _________________________________ 
2. No 
 
Health Behaviors 
 
Conservative therapies   Pre During     Post 
Yes (1)          Total Number _____ 
 No  (0) 
 _____Fluid/dietary management ____      ____       ____ 
 _____Bowel management  ____      ____       ____ 
 _____Kegel exercises   ____   ____       ____ 
 
Medications      
Yes (1) 
No  (0) 
_____Diuretics 
_____CNS depressants 
_____Hormones 
_____Anticholinergics 
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_____Antihistamines 
_____Other _____________________________________________ 
 
Substance Use    
Yes (1) 
No  (0) 
    
_____Tobacco _____Never smoked 
_____Currently smoking   
           _____Cigarettes per day 
           _____Cigars per day 
           _____Pipes per day 
           _____Smokeless tobacco per day 
_____Smoked in the past   ________time since cessation 
   
_____Caffeinated beverages 
   Type___________________________________  
    
   ______ number per day 
  
_____Alcohol 
   Type___________________________________ 
    
   ______number per day 
 
Physical Findings 
 
No  (0) 
Yes (1)    Station with respect to introitus 
(1) Slight  
(2) To introitus   
(3) Beyond introitus 
 
_____Cystocele            _____ 
 
_____Rectocele   _____ 
 
_____Uterine prolapse  ____ 
 
Abnormal (0)    Not Sustained (0) 
Normal (1)    Sustained (1) 
 
_____Vaginal tone  _____ grip 
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_____Rectal tone  _____grip 
 
Urodynamics results ____________________________________________________ 
 
Treatment Protocol 
 
Number of Treatments   _____tx week X _____weeks 
 
Prescription     _____Hz_____Min. 
      _____Min. rest 
      _____Hz_____Min. 
Outcome Measures 
 
 First Evaluation Midpoint Final 
Evaluation 
Number of Daily  
Wetting Episodes 
   
Number of Daily 
Pad Use 
   
 
Repeated Protocol    _____ 
 
1. Yes 
How long between protocols_____________ 
 
Number of Treatments  _____tx week X_____weeks 
 
Prescription    _____Hz_____Min. 
     _____Min. rest 
     _____Hz_____Min.  
2. No 
 
Repeated Protocol 
 First Evaluation Midpoint Final 
Evaluation 
Number of Daily  
Wetting Episodes 
   
Number of Daily 
Pad Use 
   
 
 
